<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TPX</journal-id>
<journal-id journal-id-type="hwp">sptpx</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Pathol</journal-id>
<journal-title>Toxicologic Pathology</journal-title>
<issn pub-type="ppub">0192-6233</issn>
<issn pub-type="epub">1533-1601</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0192623311430693</article-id>
<article-id pub-id-type="publisher-id">10.1177_0192623311430693</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Session 3: Acquired Immunity</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Regulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Peterson</surname>
<given-names>Richard A.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0192623311430693"/>
<xref ref-type="corresp" rid="corresp1-0192623311430693"/>
</contrib>
<aff id="aff1-0192623311430693">GlaxoSmithKline, Research Triangle Park, North Carolina, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0192623311430693">Richard A. Peterson II, DVM, PhD, DACVP, Safety Assessment, 9.3009.2D, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709; phone: (919) 315-2450; fax: (919) 483-6858; e-mail: <email>richard.a.peterson@gsk.com</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>40</volume>
<issue>2</issue>
<fpage>186</fpage>
<lpage>204</lpage>
<permissions>
<copyright-statement>© Society of Toxicologic Pathology 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society of Toxicologic Pathology</copyright-holder>
</permissions>
<abstract>
<p>Regulatory T-cells (T<sub>REG</sub>) are diverse populations of lymphocytes that regulate the adaptive immune response in higher vertebrates. T<sub>REG</sub> delete autoreactive T-cells, induce tolerance, and dampen inflammation. T<sub>REG</sub> cell deficiency in humans (i.e., IPEX [Immunodysregulation, Polyendocrinopathy and Enteropathy, X-linked syndrome]) and animal models (e.g., “Scurfy” mouse) is associated with multisystemic autoimmune disease. T<sub>REG</sub> in humans and laboratory animal species are similar in type and regulatory function. A molecular marker of and the cell lineage specification factor for T<sub>REG</sub> is FOXP3, a forkhead box transcription factor. CD4<sup>+</sup> T<sub>REG</sub> are either natural (nT<sub>REG</sub>), which are thymus-derived CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> T-cells, or inducible (i.e., Tr1 cells that secrete IL-10, Th3 cells that secrete TGF-β and IL-10, and Foxp3<sup>+</sup> Treg). The proinflammatory Th17 subset has been a major focus of research. T<sub>H</sub>17 CD4<sup>+</sup> effector T-cells secrete IL-17, IL-21, and IL-22 in autoimmune and inflammatory disease, and are dynamically balanced with T<sub>REG</sub> cell development. Other lymphocyte subsets with regulatory function include: inducible CD8<sup>+</sup> T<sub>REG</sub>, CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup> T<sub>REG</sub> (double-negative), CD4<sup>+</sup>Vα14<sup>+</sup> (NKT<sub>REG</sub>), and γδ T-cells. T<sub>REG</sub> have four regulatory modes of action: secretion of inhibitory cytokines (e.g., IL-10 and TGF-β), granzyme-perforin-induced apoptosis of effector lymphocytes, depriving effector T-cells of cytokines leading to apoptosis, or inhibition of dendritic cell function. The role of T<sub>REG</sub> in mucosal sites, inflammation/infection, pregnancy, and cancer as well as a review of T<sub>REG</sub> as a modulatory target in drug development will be covered.</p>
</abstract>
<kwd-group>
<kwd> immunopathology; regulatory T-cells; lymphocytes; flow cytometry; Scurfy mouse; FOXP3; IPEX.</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0192623311430693">
<title>Introduction to Regulatory T-Cells</title>
<p>This article will review the scientific literature and provide an overview of Regulatory T-cell (T<sub>REG</sub>) characterization, function, role in the immune response, at mucosal sites, during pregnancy and in the tumor microenvironment, and as a target for modulation in drug development. There has been enhanced focus on the T<sub>REG</sub> in the field of immunology, which translates into a prominent increase in the number of citations over the past decade (<xref ref-type="fig" rid="fig1-0192623311430693">Figure 1</xref>).</p>
<fig id="fig1-0192623311430693" position="float">
<label>Figure 1.</label>
<caption>
<p>There has been a steady increase in the number of regulatory T-cell (T<sub>REG</sub>) citations in the scientific literature from the mid-1990s to the present (from Scopus). The key milestones in T<sub>REG</sub> research are highlighted on the horizontal axis.</p>
</caption>
<graphic alternate-form-of="fig1-0192623311430693" xlink:href="10.1177_0192623311430693-fig1.tif"/>
</fig>
<p>T<sub>REG</sub> are diverse populations of lymphocytes that regulate the adaptive immune response in higher vertebrates. T<sub>REG</sub> delete autoreactive T-cells, induce tolerance, and dampen inflammation (<xref ref-type="bibr" rid="bibr4-0192623311430693">Akdis 2009</xref>; <xref ref-type="bibr" rid="bibr118-0192623311430693">Ozdemir et al. 2009</xref>; <xref ref-type="bibr" rid="bibr43-0192623311430693">Dittel 2008</xref>; <xref ref-type="bibr" rid="bibr116-0192623311430693">Orihara et al. 2008</xref>; <xref ref-type="bibr" rid="bibr134-0192623311430693">Sakaguchi et al. 2008</xref>; <xref ref-type="bibr" rid="bibr147-0192623311430693">Simpson 2008</xref>; <xref ref-type="bibr" rid="bibr20-0192623311430693">Bluestone and Tang 2005</xref>; <xref ref-type="bibr" rid="bibr34-0192623311430693">Coutinho et al. 2005</xref>).</p>
<p>Over the past 40 years, the field of immunology has slowly evolved, becoming much more complex than was initially hypothesized in the 1960s. Between 1966 and 1968, several groups identified B-lymphocytes as the source of the antibody response and T-lymphocytes as critical in the delayed-type hypersensitivity (DTH) response (<xref ref-type="bibr" rid="bibr30-0192623311430693">Claman et al. 1966</xref>; <xref ref-type="bibr" rid="bibr102-0192623311430693">Mosier 1967</xref>; Mitchell et al. 1968). In 1971, Gershon and Kondo identified negative interference on positively acting lymphocytes during inflammation and referred to it as “infectious immunological tolerance” (Gershon and Kondo 1971). This was the first indication that a “suppressive” process was active during inflammation. The “suppressor T-cell” hypothesis was put forth by two groups in the later years of the 1970s (<xref ref-type="bibr" rid="bibr164-0192623311430693">Vadas et al. 1976</xref>; <xref ref-type="bibr" rid="bibr115-0192623311430693">Okumura et al. 1977</xref>). A series of negative results from experiments conducted by several groups led to a loss of confidence in the “suppressor T-cell” hypothesis, rejection of the hypothesis by the field of immunology, and more recently reacceptance (<xref ref-type="bibr" rid="bibr69-0192623311430693">Kapp and Bucy 2008</xref>; <xref ref-type="bibr" rid="bibr50-0192623311430693">Germain 2008</xref>; <xref ref-type="bibr" rid="bibr84-0192623311430693">Lehner 2008</xref>). The rejection of the “suppressor T-cell” hypothesis did not explain away the presence of a dampening of immune responses commonly seen in the inflammatory milieu. In 1989, Mosmann and Coffman identified the T-helper (T<sub>H</sub>)-1 and (T<sub>H</sub>)-2 CD4<sup>+</sup> T-cell subsets based upon the profiles of cytokines secreted after activation. T<sub>H</sub>1 cells primarily secrete IFN-γ, IL-15, and TNF-α, while T<sub>H</sub>2 cells secrete IL-4, IL-5, IL-6, and IL-13. Powrie et al. showed in severe combined immunodeficient (SCID) mice that subsets of CD4<sup>+</sup> T-cells induce and protect from intestinal inflammation (<xref ref-type="bibr" rid="bibr121-0192623311430693">Powrie et al. 1994</xref>). This once again defined a population of lymphocytes with immunosuppressive actions, which was identified as a population expressing CD45RB<sup>low</sup> while the inducing cells were CD45RB<sup>high</sup>. In 1995, Sakaguchi et al. found that immunologic self-tolerance was maintained by activated CD4<sup>+</sup> T-cells expressing CD25 (IL-2R alpha chain). Depletion of this CD4<sup>+</sup>CD25<sup>+</sup> population led to development of autoimmune disease (<xref ref-type="bibr" rid="bibr133-0192623311430693">Sakaguchi et al. 1995</xref>). Two groups, Hori et al. and Fontenot et al., identified a CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> cell population that was found to be thymically derived, natural T<sub>REG</sub> cells (<xref ref-type="bibr" rid="bibr61-0192623311430693">Hori et al. 2003</xref>; <xref ref-type="bibr" rid="bibr45-0192623311430693">Fontenot et al. 2003</xref>, 2005). FOXP3 has been shown to be critical for regulatory action of most subtypes of T<sub>REG</sub>.</p>
</sec>
<sec id="section2-0192623311430693">
<title>Types of Regulatory T-Cells (T<sub>REG</sub>, Natural, and Adaptive/Induced) CD4<sup>+</sup>CD25<sup>+</sup> T<sub>REG</sub>
</title>
<p>Natural T<sub>REG</sub> are thymus-derived CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> T-cells (<xref ref-type="fig" rid="fig2-0192623311430693">Figure 2</xref>). They arise in the thymus during early stages of human fetal development (gestational week 14) (<xref ref-type="bibr" rid="bibr36-0192623311430693">Cupedo et al. 2005</xref>) and are resistant to thymic deletion (<xref ref-type="bibr" rid="bibr89-0192623311430693">Lim et al. 2006</xref>). nT<sub>REG</sub> differentiate from thymocytes that express TCRs with an increased affinity for self-peptide-MHC complexes (<xref ref-type="bibr" rid="bibr89-0192623311430693">Lim et al. 2006</xref>; <xref ref-type="bibr" rid="bibr95-0192623311430693">Maggi et al. 2005</xref>; <xref ref-type="bibr" rid="bibr139-0192623311430693">Schwartz 2005</xref>). nT<sub>REG</sub> can suppress the following cell types: CD4+ T-cells, dendritic cells, CD8<sup>+</sup> T-cells, NKT cells, NK cells, monocytes/macrophages, B-cells, mast cells, basophils, eosinophils, and osteoblasts (Shevach et al. 2009; <xref ref-type="bibr" rid="bibr89-0192623311430693">Lim et al. 2006</xref>). FOXP3<sup>+ </sup>expression is necessary for thymocytes to commit to the T<sub>REG</sub> lineage (<xref ref-type="bibr" rid="bibr89-0192623311430693">Lim et al. 2006</xref>). Resting nT<sub>REG</sub> are CD45RA<sup>+</sup>FOXP3<sup>low</sup>, while activated nT<sub>REG</sub> are CD45RO<sup>+</sup>FOXP3<sup>high </sup>(<xref ref-type="bibr" rid="bibr12-0192623311430693">Beissert et al. 2006</xref>; <xref ref-type="bibr" rid="bibr89-0192623311430693">Lim et al. 2006</xref>). Natural T<sub>REG</sub> also express the following markers: T cell activation/differentiation markers (CD45RO [memory phenotype; activated], CD45RB [resting], CD25 [both]), adhesion molecules (CD62L [both], CD44 [both] and Integrin α<sub>4</sub>β<sub>7</sub> [resting]), cytotoxic T lymphocyte-associated protein-4 (CTLA-4; both), co-stimulatory molecule CD28 (both), chemokine receptors (CCR7 [both], CXCR4 [both], CCR9 [resting]), glucocorticoid-induced TNFR-related protein (GITR, both), OX40 (CD134, both), and folate receptor-4 (FR4 in rodents, both) (<xref ref-type="bibr" rid="bibr89-0192623311430693">Lim et al. 2006</xref>). IL-2 is essential for nT<sub>REG</sub> development, function, and homeostasis (i.e., CD25 is the α-chain of the high affinity IL2R) (<xref ref-type="bibr" rid="bibr96-0192623311430693">Malek et al. 2008</xref>). Severe autoimmunity is seen in IL-2-, IL2Rα-, and IL-2Rβ-deficient mice, which also lack a normal number of T<sub>REG</sub> cells (<xref ref-type="bibr" rid="bibr96-0192623311430693">Malek et al. 2008</xref>). The nT<sub>REG</sub> profile in mammals is highly conserved. Nonhuman primates have the same nT<sub>REG</sub> protein expression and functional profile as that of humans including two FOXP3 isoforms (<xref ref-type="bibr" rid="bibr130-0192623311430693">Roncarolo and Battaglia 2007</xref>; <xref ref-type="bibr" rid="bibr19-0192623311430693">Bloom 2006</xref>), while in rodents there are only subtle differences primarily in the type of granzyme expressed (i.e., B versus A) and only a single FOXP3 isoform (<xref ref-type="bibr" rid="bibr130-0192623311430693">Roncarolo and Battaglia 2007</xref>).</p>
<fig id="fig2-0192623311430693" position="float">
<label>Figure 2.</label>
<caption>
<p>T<sub>REG</sub> are either formed naturally by thymic differentiation (nT<sub>REG</sub>) or are induced in the periphery (iT<sub>REG</sub>) from naïve T-cells (T<sub>H</sub>0). Types of iT<sub>REG</sub> include T<sub>H</sub>3, T<sub>r</sub>1, which are CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup>, and CD4<sup>+</sup>CD25<sup>-</sup>FOXP3<sup>+</sup> iT<sub>REG</sub>. The main effector CD4+ subsets are T<sub>H</sub>1, T<sub>H</sub>2, and T<sub>H</sub>17. The cytokines that are important in inducing these cells from T<sub>H</sub>0 cells and the cytokines that these cells secrete are listed.</p>
</caption>
<graphic alternate-form-of="fig2-0192623311430693" xlink:href="10.1177_0192623311430693-fig2.tif"/>
</fig>
</sec>
<sec id="section3-0192623311430693">
<title>Adaptive/Induced T<sub>REG</sub>
</title>
<p>The two most common types of adaptive or induced T<sub>REG</sub> are the T regulatory type 1 cells (T<sub>r</sub>1) and T<sub>H</sub>3 T<sub>REG</sub> cells (<xref ref-type="fig" rid="fig2-0192623311430693">Figure 2</xref>). T<sub>r</sub>1 cells secrete IL-10 and also have an IL-10-dependent induction process (<xref ref-type="bibr" rid="bibr48-0192623311430693">Fujio et al. 2010</xref>; <xref ref-type="bibr" rid="bibr12-0192623311430693">Beissert et al. 2006</xref>; <xref ref-type="bibr" rid="bibr131-0192623311430693">Roncarolo et al. 2006</xref>). They are capable of secreting high levels of IL-10 and TGF-β in the human and mouse and also secrete low levels of IL-2, IL-5, and IFN-γ (<xref ref-type="bibr" rid="bibr48-0192623311430693">Fujio et al. 2010</xref>; <xref ref-type="bibr" rid="bibr131-0192623311430693">Roncarolo et al. 2006</xref>). An important growth factor for T<sub>r</sub>1 cells is IL-15, which can support T<sub>r</sub>1 cell proliferation even without TCR activation (<xref ref-type="bibr" rid="bibr48-0192623311430693">Fujio et al. 2010</xref>; <xref ref-type="bibr" rid="bibr131-0192623311430693">Roncarolo et al. 2006</xref>). They are CD4+, anergic, and proliferate poorly upon antigen-specific activation which is likely due to the autocrine production of IL-10 leading to suppression of proliferation (<xref ref-type="bibr" rid="bibr48-0192623311430693">Fujio et al. 2010</xref>; <xref ref-type="bibr" rid="bibr131-0192623311430693">Roncarolo et al. 2006</xref>). The mechanism of suppressive effects with T<sub>r</sub>1 cells is soluble factor-based (i.e., IL-10), and the suppressive effects of T<sub>r</sub>1 cells are negated by anti-IL-10 neutralizing antibody <italic>in vitro </italic>(<xref ref-type="bibr" rid="bibr48-0192623311430693">Fujio et al. 2010</xref>; <xref ref-type="bibr" rid="bibr131-0192623311430693">Roncarolo et al. 2006</xref>). There is no specific marker for T<sub>r</sub>1 cells, although repressor of GATA-3 (ROG) shows potential utility (<xref ref-type="bibr" rid="bibr48-0192623311430693">Fujio et al. 2010</xref>; <xref ref-type="bibr" rid="bibr131-0192623311430693">Roncarolo et al. 2006</xref>), but it is not specific for this cell population.</p>
<p>T<sub>H</sub>3 cells secrete TGF-β and IL-10 and express FOXP3 (<xref ref-type="bibr" rid="bibr12-0192623311430693">Beissert et al. 2006</xref>). They are induced from naïve CD4<sup>+</sup> T-cells by TGF-β and have an important role in oral tolerance to non-self antigens and negating autoimmune reactions (<xref ref-type="bibr" rid="bibr170-0192623311430693">Wan and Flavell 2007</xref>). T<sub>H</sub>3 cells secrete TGF-β, which has immunosuppressive effects acting through a soluble-factor mechanism. T<sub>H</sub>3 cells have a reciprocal relationship with T<sub>H</sub>17 cells (<xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref>; <xref ref-type="bibr" rid="bibr110-0192623311430693">Nistala and Wedderburn 2009</xref>). T<sub>H</sub>17 cells are highly proinflammatory and are thought to be important in autoimmune disease (<xref ref-type="bibr" rid="bibr2-0192623311430693">Abraham and Cho 2009</xref>; <xref ref-type="bibr" rid="bibr35-0192623311430693">Crome et al. 2009</xref>; <xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref>; <xref ref-type="bibr" rid="bibr110-0192623311430693">Nistala and Wedderburn 2009</xref>; <xref ref-type="bibr" rid="bibr128-0192623311430693">Romagnani et al. 2009</xref>); this will be discussed in detail later in the article. There has been no specific surface marker identified for T<sub>H</sub>3 cells, although expression of FOXP3 is induced in T<sub>H</sub>3 cells (i.e., cannot differentiate from nT<sub>REG</sub>) (<xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref>).</p>
</sec>
<sec id="section4-0192623311430693">
<title>Other T-Cells with Regulatory Function</title>
<p>Other T-cell populations that have been shown to have regulatory function include inducible CD8<sup>+</sup> T<sub>REG</sub> cells, CD8<sup>+</sup>CD28<sup>−</sup> T<sub>REG</sub> cells, and CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup> T<sub>REG</sub> (double-negative [DN]). CD8<sup>+</sup> T<sub>REG</sub> (<xref ref-type="bibr" rid="bibr69-0192623311430693">Kapp and Bucy 2008</xref>; <xref ref-type="bibr" rid="bibr12-0192623311430693">Beissert et al. 2006</xref>; <xref ref-type="bibr" rid="bibr106-0192623311430693">Nakamura et al. 2003</xref>; <xref ref-type="bibr" rid="bibr72-0192623311430693">Ke and Kapp 1996</xref>; <xref ref-type="bibr" rid="bibr66-0192623311430693">Jiang et al. 1992</xref>) are CD8<sup>+</sup> T-cells that have regulatory activity on CD4<sup>+</sup> T<sub>H</sub>1 cells. This T<sub>REG</sub> population inhibits priming of CD8<sup>+</sup> T-cells, CD4<sup>+</sup> T-cells, and antibody responses against oral antigens. They are induced by manipulation of co-stimulatory molecule interactions (i.e., CD137 and CD40) primarily, although antigens introduced into immune privileged sites (i.e., anterior chamber of eye leading to anterior chamber-associated autoimmune deviation [ACAID]) elicit CD8<sup>+</sup> T<sub>REG</sub> due to high levels of TGF-β and IL-10 at this site (<xref ref-type="bibr" rid="bibr17-0192623311430693">Biros 2008</xref>; <xref ref-type="bibr" rid="bibr109-0192623311430693">Niederkorn 2008</xref>). They have also been shown to arise spontaneously in Experimental Allergic Encephalitis (EAE) and murine Ovalbumin-induced oral tolerance models and in tumor-bearing hosts due to IL-10 secretion by APCs in the neoplasm. They are well characterized in rodents, but their importance in humans is uncertain. CD8<sup>+</sup>CD28<sup>- </sup>T<sub>REG</sub> (<xref ref-type="bibr" rid="bibr33-0192623311430693">Cortesini et al. 2001</xref>; <xref ref-type="bibr" rid="bibr26-0192623311430693">Chang et al. 2002</xref>) are FOXP3<sup>−</sup> and are induced by inhibitory immunoglobulin-like transcript (ILT)-3 and ILT-4 receptor expression on dendritic cells and down-regulation of CD80 and CD86. They interfere with the CD28/B7 pathway with allogeneic antigens and CD154/CD40 pathway with xenogeneic antigens. CD8<sup>+</sup>CD28<sup>−</sup> T<sub>REG</sub> regulate immune responses by direct cell-to-cell interactions with dendritic cells; therefore they are directly tolerogenic. This cell population has been described in rodents and humans. CD3<sup>+</sup>CD4<sup>−</sup>CD8<sup>−</sup> (DN) T<sub>REG</sub> are TCRαβ<sup>+</sup>, CD4<sup>−</sup>, and CD8<sup>−</sup> (therefore DN). They promote the development of tolerance and regulate autoimmunity (<xref ref-type="bibr" rid="bibr149-0192623311430693">Strober et al. 1996</xref>). This cell population has been defined and characterized in heart xenotransplantation experiments (<xref ref-type="bibr" rid="bibr27-0192623311430693">Chen et al. 2003</xref>, <xref ref-type="bibr" rid="bibr29-0192623311430693">2005</xref>; <xref ref-type="bibr" rid="bibr186-0192623311430693">Zhang et al. 2006</xref>; <xref ref-type="bibr" rid="bibr94-0192623311430693">Ma et al. 2008</xref>). DN T<sub>REG </sub>are poorly suppressive in naïve mice but are actively suppressive in recipients of heart xenografts co-transferred with donor DN Tregs. They have been shown to prevent heart xenograft rejection (i.e., transplant tolerance). It has been shown that antigen presenting cells (APC) from tolerant mice had down-regulation of MHCII, CD40, and B7 molecules, and likely were in an immature state. The significance of DN T<sub>REG</sub> in nontransplant scenarios is therefore uncertain and more data is needed.</p>
</sec>
<sec id="section5-0192623311430693">
<title>CD4<sup>+</sup>Vα14<sup>+</sup> (NKT<sub>REG</sub>)</title>
<p>Natural killer T-cells coexpress NK receptors (i.e., NK1.1 or CD161) as well as a conserved T-cell receptor (TCR) molecule (<xref ref-type="bibr" rid="bibr12-0192623311430693">Beissert et al. 2006</xref>), Vα14. Vα14 pairs with Vβ8 in the mouse and Vβ11 in the human and are restricted by CD1d, a conserved MHCI-type molecule that presents glycolipids. NKT<sub>REG</sub> cells are generated in the thymus and can be CD4<sup>+</sup>, CD8<sup>+</sup>, DN, or double positive (DP). In mice, DN NKT<sub>REG</sub> are the dominant phenotype (<xref ref-type="bibr" rid="bibr184-0192623311430693">Zeng et al. 1999</xref>); while in humans, CD4<sup>+</sup> NKT<sub>REG</sub> are most efficient (<xref ref-type="bibr" rid="bibr65-0192623311430693">Jiang et al. 2005</xref>). They have been studied primarily in rodent xenogeneic transplantation models (<xref ref-type="bibr" rid="bibr63-0192623311430693">Ikehara et al. 2000</xref>). They secrete IL-4, IL-10, TGF-β (paracrine), and induce cytotoxicity by cell-to-cell contact, and the targets of NKT<sub>REG</sub> cells are T-cells and APCs (<xref ref-type="bibr" rid="bibr63-0192623311430693">Ikehara et al. 2000</xref>; <xref ref-type="bibr" rid="bibr184-0192623311430693">Zeng et al. 1999</xref>). The significance of NKT<sub>REG</sub> cells in immune regulation outside of xenotransplantation is uncertain.</p>
</sec>
<sec id="section6-0192623311430693">
<title>γδ T-Cells (Mucosal/Intraepithelial)</title>
<p>Gamma delta (γδ) T-cells, which express TCRγδ and have a mucosal distribution, are primarily suppressive and are associated with mucosal tolerance (<xref ref-type="bibr" rid="bibr71-0192623311430693">Kapp and Ke 1997</xref>; <xref ref-type="bibr" rid="bibr73-0192623311430693">Ke et al. 1997</xref>; <xref ref-type="bibr" rid="bibr103-0192623311430693">Mowat 1994</xref>), but can also function to regulate autoimmunity (<xref ref-type="bibr" rid="bibr174-0192623311430693">Weiner et al. 1994</xref>), elicit ACAID in the eye (<xref ref-type="bibr" rid="bibr17-0192623311430693">Biros 2008</xref>), and function in tumor immunity (<xref ref-type="bibr" rid="bibr141-0192623311430693">Seo et al. 1999</xref>). These cells do not recognize peptides associated with MHC receptors (<xref ref-type="bibr" rid="bibr78-0192623311430693">Kronenberg 1994</xref>); alternatively they recognize cellular proteins including heat shock proteins (<xref ref-type="bibr" rid="bibr105-0192623311430693">Munk et al. 1989</xref>) and nonclassic MHC molecules like CD1 (<xref ref-type="bibr" rid="bibr22-0192623311430693">Brossay et al. 1998</xref>) and Qa-1 (<xref ref-type="bibr" rid="bibr167-0192623311430693">Vidovic et al. 1989</xref>). γδ T-cells that infiltrate tumors have cytokine profiles that are similar to T<sub>r</sub>1 cells (i.e., IL-10 and TGF-β) and inhibit the immune response against neoplasia (<xref ref-type="bibr" rid="bibr70-0192623311430693">Kapp et al. 2004</xref>; <xref ref-type="bibr" rid="bibr140-0192623311430693">Seo and Tokura 1999</xref>; <xref ref-type="bibr" rid="bibr141-0192623311430693">Seo et al. 1999</xref>; <xref ref-type="bibr" rid="bibr71-0192623311430693">Kapp and Ke 1997</xref>; <xref ref-type="bibr" rid="bibr73-0192623311430693">Ke et al. 1997</xref>). Therefore, γδ T-cells are a minor population of mucosal and intratumoral T-cells with regulatory activity and major roles in mucosal tolerance and tumor immunity.</p>
</sec>
<sec id="section7-0192623311430693">
<title>A Non-T Lymphocyte Subset with Regulatory Function</title>
<p>Another cell type exhibiting regulatory activity is the regulatory B-cell (B<sub>REG</sub>) which has been recently reviewed by <xref ref-type="bibr" rid="bibr88-0192623311430693">Li et al. (2011)</xref>. B<sub>REG</sub> cells are beyond the scope of this review, but are mentioned here briefly to showcase the diversity of lymphocytes with regulatory function in the immune system and for completeness-sake. B<sub>REG</sub> cells have been shown in various animal disease models, including collagen-induced arthritis (<xref ref-type="bibr" rid="bibr161-0192623311430693">Trentham et al. 1977</xref>), experimental autoimmune encephalitis (EAE) (<xref ref-type="bibr" rid="bibr177-0192623311430693">Wolf et al. 1996</xref>), nonobese diabetes mellitus (<xref ref-type="bibr" rid="bibr159-0192623311430693">Tian et al. 2001</xref>), inflammatory bowel disease (<xref ref-type="bibr" rid="bibr100-0192623311430693">Mizoguchi et al. 2000</xref>), and systemic lupus erythematosus (<xref ref-type="bibr" rid="bibr86-0192623311430693">Lenert et al. 2005</xref>), and function primarily to regulate T-cells, B-cells, and NKT cells. B<sub>REG</sub> cells act by soluble factor-based means by secreting IL-10 (<xref ref-type="bibr" rid="bibr124-0192623311430693">Reigert and Bar-Or 2008</xref>), TGF-β (<xref ref-type="bibr" rid="bibr152-0192623311430693">Takenoshita et al. 2002</xref>) and producing anti-inflammatory antibodies (<xref ref-type="bibr" rid="bibr41-0192623311430693">Diamond et al. 2003</xref>). Cell-cell interactions are an important mode of B<sub>REG</sub> regulatory function and include CD1d binding (<xref ref-type="bibr" rid="bibr180-0192623311430693">Yanaba et al. 2008</xref>) by CD1d<sup>hi</sup>CD5<sup>+</sup> cells and CD40/CD40 L interactions (<xref ref-type="bibr" rid="bibr122-0192623311430693">Quezada et al. 2004</xref>). More research into specific roles for B<sub>REG</sub>
is needed to more completely define this cell type.</p>
</sec>
<sec id="section8-0192623311430693">
<title>T<sub>REG</sub> Basics</title>
<p>T<sub>REG</sub> cells function at sites of inflammation in close spatial proximity to effector T-cells, thus allowing direct interactions between the two cell types (<xref ref-type="bibr" rid="bibr8-0192623311430693">Askenasy et al. 2008</xref>). T<sub>REG</sub> cells are attracted by inflammatory signals, although they are less chemotactic than effector T-cells (<xref ref-type="bibr" rid="bibr146-0192623311430693">Siegmund et al. 2005</xref>). When arriving at the site of inflammation, T<sub>REG</sub> down-regulate chemotactic receptors and adhesive interactions to arrest further migration (<xref ref-type="bibr" rid="bibr146-0192623311430693">Siegmund et al. 2005</xref>). nT<sub>REG</sub> are mitotically inactive under basal conditions (<xref ref-type="bibr" rid="bibr80-0192623311430693">Kuniyasu et al. 2000</xref>). Activated T<sub>REG</sub>-mediated immune suppression is antigen-nonspecific (i.e., not MHCII-restricted) (<xref ref-type="bibr" rid="bibr16-0192623311430693">Bienvenu et al. 2005</xref>), although induction of suppressor function in T<sub>REG</sub> requires antigen-specific stimulation (i.e., via TCR) leading to tissue-specific suppressive effects (“bystander” suppression) (<xref ref-type="bibr" rid="bibr144-0192623311430693">Shevach 2009</xref>; <xref ref-type="bibr" rid="bibr173-0192623311430693">Weiner 1997</xref>). T<sub>REG</sub> have also been associated with regulating lymphopenia-induced lymphocyte proliferation, which is a normal homeostatic event that occurs after lymphopenia of numerous causes including those of a physiologic and pathologic nature. Lymphopenia-induced lymphocyte proliferation does not increase the number of naïve lymphocytes, but instead the number of memory T-cells increase, which might result in potential self-reactive clones and subsequent autoimmunity. T<sub>REG</sub> have an important role in regulating this process (<xref ref-type="bibr" rid="bibr37-0192623311430693">Datta and Sarvetnick 2009</xref>).</p>
</sec>
<sec id="section9-0192623311430693">
<title>Effects of Acute and Chronic Stress on Human T<sub>REG</sub>
</title>
<p>βeta 1-adrenergic and glucocorticoid α receptors are overexpressed in T<sub>REG</sub> versus effector T-cells (Freier et al. 2010; <xref ref-type="bibr" rid="bibr10-0192623311430693">Atanackovic et al. 2006</xref>). These receptors likely mediate T<sub>REG</sub> responses to stress (Freier et al. 2010; <xref ref-type="bibr" rid="bibr10-0192623311430693">Atanackovic et al. 2006</xref>). T<sub>REG</sub> numbers have been shown to decrease with acute physiologic stress (Freier et al. 2010; <xref ref-type="bibr" rid="bibr10-0192623311430693">Atanackovic et al. 2006</xref>; <xref ref-type="bibr" rid="bibr9-0192623311430693">Atanackovic et al. 2002</xref>). Based on these findings, chronic stress could exacerbate autoimmune disease and other inflammatory conditions (Freier et al. 2010).</p>
</sec>
<sec id="section10-0192623311430693">
<title>Modes of Action of T<sub>REG</sub> Regulation</title>
<p>T<sub>REG</sub> have primary effect on T-cells and/or dendritic cells by three main regulatory modes of action: (1) soluble factors (<xref ref-type="fig" rid="fig3-0192623311430693">Figure 3</xref>), (2) cell-to-cell contact (<xref ref-type="fig" rid="fig4-0192623311430693">Figure 4</xref>) and (3) competition for growth factors (local effect) (<xref ref-type="fig" rid="fig5-0192623311430693">Figure 5</xref>). Soluble factors include IL-10 and TGF-β with direct suppressive effects on effector T-cells (<xref ref-type="bibr" rid="bibr67-0192623311430693">Joetham et al. 2007</xref>; <xref ref-type="bibr" rid="bibr7-0192623311430693">Annacker et al. 2003</xref>), fibrinogen-like protein-2 (FLG-2) with apoptotic effects on effector T-cells and prevention of maturation of dendritic cells (<xref ref-type="bibr" rid="bibr142-0192623311430693">Shalev et al. 2009</xref>), granzyme A/B and perforin apoptotic effects on effector T-cells (<xref ref-type="bibr" rid="bibr54-0192623311430693">Grossman et al. 2004</xref>), and production of adenosine by CD39/73 cleavage of ATP, which causes cell cycle arrest in effector T-cells and prevention of maturation and decreased antigen presenting capability in dendritic cells by binding to the A<sub>2A</sub> receptor on these cell types (<xref ref-type="bibr" rid="bibr38-0192623311430693">Deaglio et al. 2007</xref>). Galectin-1 binding to effector T-cells and dendritic cells resulting in cell cycle arrest and/or apoptosis (<xref ref-type="bibr" rid="bibr49-0192623311430693">Garin et al. 2007</xref>), CTLA4 and CD80/86 binding to dendritic cells causing decreased costimulation and decreased antigen presentation (<xref ref-type="bibr" rid="bibr123-0192623311430693">Read et al. 2000</xref>), lymphocyte activating gene-3 (LAG3 or CD223, a CD4 homolog) binding to MHCII molecules on dendritic cells leading to prevention of maturation and a reduction in antigen presentation capability (<xref ref-type="bibr" rid="bibr178-0192623311430693">Workman and Vignali 2004</xref>), and neuropilin-1 binding to dendritic cells resulting in decreased antigen presentation (<xref ref-type="bibr" rid="bibr136-0192623311430693">Sarris et al. 2008</xref>) are examples of cell contact-based mediated effects of T<sub>REG</sub>. T<sub>REG</sub> can also deny IL-2 to other inflammatory cells by binding the cytokine and acting as a “sink” leading to effector T-cell apoptosis (<xref ref-type="bibr" rid="bibr119-0192623311430693">Pandiyan et al. 2007</xref>). Therefore, T<sub>REG</sub> have a variety of mechanisms that can be used to suppress an immune response and are able to use all or a subset of these mechanisms simultaneously.</p>
<fig id="fig3-0192623311430693" position="float">
<label>Figure 3.</label>
<caption>
<p>T<sub>REG</sub> can cause suppression of effector T-cells and dendritic cells through secretion of soluble factors including IL-10, TGF-β, fibrinogen-like protein-2 (FLG-2), granzyme A or B and perforin, and adenosine. The figure shows the signaling pathways and the suppressive effects on effector T-cells and dendritic cells.</p>
</caption>
<graphic alternate-form-of="fig3-0192623311430693" xlink:href="10.1177_0192623311430693-fig3.tif"/>
</fig>
<fig id="fig4-0192623311430693" position="float">
<label>Figure 4.</label>
<caption>
<p>T<sub>REG</sub> can cause suppression of effector T-cells and dendritic cells through cell contact-based mechanisms, including galectin-1 binding, CTLA-4 binding to CD80/86, lymphocyte activation gene-3 (LAG-3) binding to MHCII molecules, and neuropilin-1 binding. The figure shows the ligands, receptors, and the suppressive effects on effector T-cells and dendritic cells.</p>
</caption>
<graphic alternate-form-of="fig4-0192623311430693" xlink:href="10.1177_0192623311430693-fig4.tif"/>
</fig>
<fig id="fig5-0192623311430693" position="float">
<label>Figure 5.</label>
<caption>
<p>T<sub>REG</sub> can cause suppression of effector T-cells by providing competition for growth factors (primarily IL-2), which is essential for their survival in the periphery. T<sub>REG</sub> express multiple copies of IL-2R/CD25, which bind up local IL-2 competing with effector T-cells for IL-2 stimulation. The figure shows the ligands, receptors, and the suppressive effects on effector T-cells.</p>
</caption>
<graphic alternate-form-of="fig5-0192623311430693" xlink:href="10.1177_0192623311430693-fig5.tif"/>
</fig>
</sec>
<sec id="section11-0192623311430693">
<title>T<sub>REG</sub> Markers (Immunohistochemistry, Flow Cytometry, Intravital Microscopy, and miRNA Analysis)</title>
<p>Immunofluorescent and chromogenic IHC and flow cytometry (de Boer et al. 2007; <xref ref-type="bibr" rid="bibr129-0192623311430693">Roncador et al. 2005</xref>) for the following markers has been shown to be useful in characterizing T<sub>REG</sub> in tissue sections and isolated cells: FOXP3 (<xref ref-type="fig" rid="fig6-0192623311430693">Figures 6</xref>, <xref ref-type="fig" rid="fig7-0192623311430693">7</xref>, <xref ref-type="fig" rid="fig8-0192623311430693">8</xref>, and 9), CD25 (alpha chain of IL2R) (<xref ref-type="fig" rid="fig7-0192623311430693">Figures 7</xref>, <xref ref-type="fig" rid="fig8-0192623311430693">8</xref>, and 9), and CD62L (L-Selectin) (<xref ref-type="fig" rid="fig6-0192623311430693">Figures 6</xref> and <xref ref-type="fig" rid="fig7-0192623311430693">7</xref>). Intercellular interactions of T<sub>REG</sub> cells and effector T-cells have been visualized in rodent models using intravital microscopy (<xref ref-type="bibr" rid="bibr153-0192623311430693">Tang and Krummel 2006</xref>). Differences in micro-RNA (miRNA) in human T<sub>REG</sub> versus effector T-cells have been shown (<xref ref-type="bibr" rid="bibr59-0192623311430693">Hezova et al. 2010</xref>). There was a significant increase in miR-146a and decreases in miR-20b, 31, 99a, 100, 125b, 151, 335, and 365 in T<sub>REG</sub> when compared with effector T-cells. The pattern of increased expression of miR-146a in combination with decreases in the other miRNAs is a possible marker of T<sub>REG</sub>.</p>
<fig id="fig6-0192623311430693" position="float">
<label>Figure 6.</label>
<caption>
<p>FOXP3 and CD3 dual immunofluorescence on tissue from an area of inflammation. Note the green nuclear labeling (FOXP3<sup>+</sup>) and the red cytoplasmic labelling (CD3<sup>+</sup>). The image shows a group of T-cells with several FOXP3<sup>+</sup> T<sub>REG</sub> cells in the field. 400× magnification.</p>
</caption>
<graphic alternate-form-of="fig6-0192623311430693" xlink:href="10.1177_0192623311430693-fig6.tif"/>
</fig>
<fig id="fig7-0192623311430693" position="float">
<label>Figure 7.</label>
<caption>
<p>Flow cytometry was performed on blood from male and female CD-IGS rats to evaluate the percentage of CD4<sup>+</sup>CD25<sup>+</sup>CD62L<sup>+</sup>FOXP3<sup>+</sup> (nT<sub>REG</sub> and iT<sub>REG</sub>) cells. The image highlights the gating strategy and steps used in this evaluation.</p>
</caption>
<graphic alternate-form-of="fig7-0192623311430693" xlink:href="10.1177_0192623311430693-fig7.tif"/>
</fig>
<fig id="fig8-0192623311430693" position="float">
<label>Figure 8.</label>
<caption>
<p>The graphs of flow cytometry data using markers useful in characterizing T<sub>REG</sub> show the percentage of CD3<sup>+</sup>CD4<sup>+</sup> cells, CD62L<sup>+</sup> cells in the CD3<sup>+</sup>CD4<sup>+</sup>population, CD25<sup>+</sup>cells in the CD3<sup>+</sup>CD4<sup>+</sup> population, and FOXP3<sup>+</sup> cells in the CD3<sup>+</sup>CD4<sup>+</sup> population cell subsets in male and female rats. There was no definitive difference in cell percentages between males and females in this evaluation.</p>
</caption>
<graphic alternate-form-of="fig8-0192623311430693" xlink:href="10.1177_0192623311430693-fig8.tif"/>
</fig>
<fig id="fig9-0192623311430693" position="float">
<label>Figure 9.</label>
<caption>
<p>The graphs of flow cytometry data show the percentages of FOXP3<sup>+</sup> cells in the CD4<sup>+</sup>CD25<sup>+</sup> population and CD25<sup>+</sup> cells in the CD4<sup>+</sup>FOXP3<sup>+</sup> population. The majority (approximately 80%) of CD4<sup>+</sup>CD25<sup>+</sup> cells are also FOXP3<sup>+</sup>, which would include nT<sub>REG </sub>and T<sub>H</sub>3 cells. Only a minority (approximately 30%) of CD4<sup>+</sup>FOXP3<sup>+</sup> cells are also CD25<sup>+</sup>, which means approximately 70% of the CD4+FOXP3+ population likely represents an iT<sub>REG</sub> cell population.</p>
</caption>
<graphic alternate-form-of="fig9-0192623311430693" xlink:href="10.1177_0192623311430693-fig9.tif"/>
</fig>
</sec>
<sec id="section12-0192623311430693">
<title>FOXP3: Function and Biology</title>
<p>FOXP3, a forkhead box transcription factor, is a molecular marker and cell lineage specification factor for T<sub>REG</sub> (<xref ref-type="bibr" rid="bibr45-0192623311430693">Fontenot et al. 2003</xref>; <xref ref-type="bibr" rid="bibr61-0192623311430693">Hori et al. 2003</xref>). FOXP3 is critical for the thymic differentiation of αβ TCR<sup>+</sup> thymocytes into nT<sub>REG</sub> (<xref ref-type="bibr" rid="bibr134-0192623311430693">Sakaguchi et al. 2008</xref>; <xref ref-type="bibr" rid="bibr45-0192623311430693">Fontenot et al. 2003</xref>; <xref ref-type="bibr" rid="bibr61-0192623311430693">Hori et al. 2003</xref>). The FOXP3 gene product is referred to as scurfin and functions by regulating a set of genes required for (1) the suppressor activity of T<sub>REG</sub>, proliferative, and metabolic fitness of T<sub>REG</sub> and (2) repressing alternative T cell differentiation pathways (<xref ref-type="bibr" rid="bibr23-0192623311430693">Brunkow et al. 2001</xref>). It has been shown that a higher level of expression of FOXP3 is sufficient for suppressive activity of non-T<sub>REG</sub> T-cells in rodents (<xref ref-type="bibr" rid="bibr134-0192623311430693">Sakaguchi et al. 2008</xref>; <xref ref-type="bibr" rid="bibr92-0192623311430693">Lourenco and La Cava 2011</xref>). Several pathways are important in the induction of FOXP3 expression including TGF-β, IL-2, retinoic acid, 17-β-estradiol, and signaling through the sphingosine-1-phosphate receptor 1 (S1PR1) (<xref ref-type="fig" rid="fig10-0192623311430693">Figure 10</xref>). TGF-β is essential for induction of FOXP3 expression in naïve T-cells (i.e., iT<sub>REG </sub>including T<sub>H</sub>3 cells), but in the human it does not necessarily confer regulatory function (<xref ref-type="bibr" rid="bibr92-0192623311430693">Lourenco and La Cava 2011</xref>).</p>
<fig id="fig10-0192623311430693" position="float">
<label>Figure 10.</label>
<caption>
<p>The figure highlights several pathways of induction of FOXP3 expression including the ligands, receptors, and/or intermediary steps in induction of gene expression. A schematic of the FOXP3 gene shows the promoters and important transcription factors that bind to the promoters. There are 11 coding exons in both the mouse and human FOXP3 genes.</p>
</caption>
<graphic alternate-form-of="fig10-0192623311430693" xlink:href="10.1177_0192623311430693-fig10.tif"/>
</fig>
</sec>
<sec id="section13-0192623311430693">
<title>FOXP3 Deficiency</title>
<sec id="section14-0192623311430693">
<title>The “Scurfy” Mouse</title>
<p>In mice (B.Cg-<italic>Foxp3<sup>sf</sup>
</italic>), a frameshift mutation in the FOXP3 gene results in a truncated protein lacking the forkhead domain and is responsible for the “Scurfy” phenotype (<xref ref-type="bibr" rid="bibr31-0192623311430693">Clark et al. 1999</xref>; <xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>; <xref ref-type="bibr" rid="bibr120-0192623311430693">Patel 2001</xref>). Scurfy is an X-linked recessive mutation in the mouse that is lethal in hemizygous males 16 to 25 days after birth (<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>; <xref ref-type="bibr" rid="bibr51-0192623311430693">Godfrey et al. 1991</xref>). Scurfy mice have an overproliferation of CD4<sup>+</sup> T-lymphocytes and other cell types due to uncontrolled cytokine secretion with extensive multiorgan infiltration due to lack of functional T<sub>REG </sub>(<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>; <xref ref-type="bibr" rid="bibr51-0192623311430693">Godfrey et al. 1991</xref>). Lymphadenopathy, parenchymal organ infiltration, and subcutaneous inflammatory cell infiltrates (e.g., ear pinnae) are prominent (<xref ref-type="fig" rid="fig11-0192623311430693">Figures 11</xref> and <xref ref-type="fig" rid="fig12-0192623311430693">12</xref>) (<xref ref-type="bibr" rid="bibr51-0192623311430693">Godfrey et al. 1991</xref>). The phenotype of Scurfy mice is similar to mouse models that lack CTLA-4 or TGF-β, and in humans with immunodysregulation, polyendocrinopathy and enteropathy, X-linked syndrome (IPEX) (<xref ref-type="bibr" rid="bibr31-0192623311430693">Clark et al. 1999</xref>; <xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>; <xref ref-type="bibr" rid="bibr120-0192623311430693">Patel 2001</xref>).</p>
<fig id="fig11-0192623311430693" position="float">
<label>Figure 11.</label>
<caption>
<p>The “Scurfy” mouse has a frameshift mutation in the forkhead box transcription factor, FOXP3. This results in early lethality due to unregulated inflammation (parenchymal organs, subcutis, and lymphoid organs are the main sites of inflammatory cell accumulation) due to the lack of functional T<sub>REG</sub> cells. Note the gross pathology image of a Scurfy mouse with marked hepato- and splenomegaly and evidence of subcutaneous lesions at the tail base.</p>
</caption>
<graphic alternate-form-of="fig11-0192623311430693" xlink:href="10.1177_0192623311430693-fig11.tif"/>
</fig>
<fig id="fig12-0192623311430693" position="float">
<label>Figure 12.</label>
<caption>
<p>Note the prominent mononuclear inflammatory cell accumulation in the dermis and upper subcutis from a “Scurfy” mouse. Hematoxylin and eosin, 200× magnification.</p>
</caption>
<graphic alternate-form-of="fig12-0192623311430693" xlink:href="10.1177_0192623311430693-fig12.tif"/>
</fig>
</sec>
<sec id="section15-0192623311430693">
<title>IPEX in Humans</title>
<p>IPEX is a rare human multisystemic autoimmune disease (X-linked: females are carriers, males have the disease) that is linked to the dysfunction of the transcriptional activator FOXP3 which results in dysfunction of regulatory T-cells with subsequent autoimmunity (<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>). Mutations in the forkhead domain of FOXP3 disrupt FOXP3 protein: DNA interactions (<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>; <xref ref-type="bibr" rid="bibr120-0192623311430693">Patel 2001</xref>). The disorder manifests with enteropathy, food allergy, massive lymphoproliferation, psoriasiform or eczematous dermatitis, nail dystrophy, autoimmune endocrinopathies (primarily insulin-dependent diabetes mellitus and autoimmune thyroid disease), Coombs-positive anemia, autoimmune thrombocytopenia, autoimmune neutropenia, tubular nephropathy, and autoimmune skin conditions such as alopecia universalis and bullous pemphigoid (<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>). Treatment for IPEX includes immunosuppressive agents (e.g., cyclosporin A, FK506) alone or in combination with steroids (<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>). There has been limited success in treating the syndrome with bone marrow transplantation (<xref ref-type="bibr" rid="bibr112-0192623311430693">Ochs et al. 2002</xref>).</p>
</sec>
</sec>
<sec id="section16-0192623311430693">
<title>T<sub>H</sub>17 cells and T<sub>REG</sub>: A Reciprocal Balance</title>
<p>T<sub>H</sub>17 cells are a subpopulation of effector T cells that are very pro-inflammatory and implicated in allergic/autoimmune disease (<xref ref-type="bibr" rid="bibr2-0192623311430693">Abraham and Cho 2009</xref>; <xref ref-type="bibr" rid="bibr35-0192623311430693">Crome et al. 2009</xref>; <xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref> and <xref ref-type="bibr" rid="bibr75-0192623311430693">2007</xref>; <xref ref-type="bibr" rid="bibr110-0192623311430693">Nistala and Wedderburn 2009</xref>; <xref ref-type="bibr" rid="bibr128-0192623311430693">Romagnani et al. 2009</xref>). T<sub>H</sub>17 cells secrete IL-17, IL-22, IL-21 and IL-17F (<xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref>, <xref ref-type="bibr" rid="bibr75-0192623311430693">2007</xref>; <xref ref-type="bibr" rid="bibr166-0192623311430693">Veldhoen et al. 2006</xref>; <xref ref-type="bibr" rid="bibr15-0192623311430693">Bettelli et al. 2006</xref>; <xref ref-type="bibr" rid="bibr97-0192623311430693">Mangan et al. 2006</xref>). TGF-β is critical in induced/adaptive T<sub>REG</sub> cell (i.e., T<sub>H</sub>3 T<sub>REG</sub>) differentiation as well as development of T<sub>H</sub>17 effector cells (<xref ref-type="bibr" rid="bibr170-0192623311430693">Wan and Flavell 2007</xref>) (<xref ref-type="fig" rid="fig13-0192623311430693">Figure 13</xref>). Naïve T-cells develop into a “transitional” cell-type that expresses FOXP3 (T<sub>H</sub>3 T<sub>REG</sub> cell marker) and ROR-γt and RORα (T<sub>H</sub>17 effector cell markers) in the presence of TGF-β (<xref ref-type="fig" rid="fig14-0192623311430693">Figure 14</xref>) (Nistala et al. 2009; <xref ref-type="bibr" rid="bibr75-0192623311430693">Korn et al. 2007</xref>; <xref ref-type="bibr" rid="bibr166-0192623311430693">Veldhoen et al. 2006</xref>; <xref ref-type="bibr" rid="bibr15-0192623311430693">Bettelli et al. 2006</xref>; <xref ref-type="bibr" rid="bibr97-0192623311430693">Mangan et al. 2006</xref>). Further exposure to TGF-β or IL-6/IL-21 in the inflammatory milieu leads to T<sub>H</sub>3 cell differentiation or T<sub>H</sub>17 effector cell differentiation (<xref ref-type="bibr" rid="bibr188-0192623311430693">Zhou et al. 2008</xref>; <xref ref-type="bibr" rid="bibr75-0192623311430693">Korn et al. 2007</xref>; <xref ref-type="bibr" rid="bibr166-0192623311430693">Veldhoen et al. 2006</xref>; <xref ref-type="bibr" rid="bibr15-0192623311430693">Bettelli et al. 2006</xref>; <xref ref-type="bibr" rid="bibr97-0192623311430693">Mangan et al. 2006</xref>). Therefore, a reciprocal balance between T<sub>H</sub>17 cells and T<sub>H</sub>3 T<sub>REG</sub> cells exists (<xref ref-type="bibr" rid="bibr15-0192623311430693">Bettelli et al. 2006</xref>) where IL-6 and IL-21 inhibit T<sub>H</sub>3 cell differentiation to the benefit of T<sub>H</sub>17 cells (<xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref>, <xref ref-type="bibr" rid="bibr75-0192623311430693">2007</xref>) and TGF-β elicits T<sub>H</sub>3 cell differentiation to the disadvantage of T<sub>H</sub>17 cells (<xref ref-type="bibr" rid="bibr188-0192623311430693">Zhou et al. 2008</xref>).</p>
<fig id="fig13-0192623311430693" position="float">
<label>Figure 13.</label>
<caption>
<p>There is a reciprocal relationship between T<sub>H</sub>17 (proinflammatory effector T-cell subset that are associated with autoimmune disease) and T<sub>H</sub>3 cells (iTREG that are CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup>), which is elicited during differentiation of naïve T<sub>H</sub>0 cells, but final differentiation depends on the cytokine milieu. TGF-β is critical in differentiation of both cell types but depends on the cytokine milieu. The schematic shows the cytokine pathways in the differentiation of T<sub>H</sub>17 and T<sub>H</sub>3 cells from T<sub>H</sub>0 effector cells.</p>
</caption>
<graphic alternate-form-of="fig13-0192623311430693" xlink:href="10.1177_0192623311430693-fig13.tif"/>
</fig>
<fig id="fig14-0192623311430693" position="float">
<label>Figure 14.</label>
<caption>
<p>This schematic focuses on the differentiation pathways of T<sub>H</sub>0 to T<sub>H</sub>17 and T<sub>H</sub>3 cells showing a transitional state (FOXP3<sup>+</sup>, ROR-γt<sup>+</sup> and RORα<sup>+</sup> cell) where addition of certain cytokines/factors drives differentiation to T<sub>H</sub>3 cells (FOXP3+) leading to suppression or T<sub>H</sub>17 cells (ROR-γt<sup>+</sup> and RORα<sup>+</sup>) resulting in inflammation/autoimmune disease.</p>
</caption>
<graphic alternate-form-of="fig14-0192623311430693" xlink:href="10.1177_0192623311430693-fig14.tif"/>
</fig>
</sec>
<sec id="section17-0192623311430693">
<title>Role of T<sub>REG</sub> in Mucosal Sites</title>
<p>Oral tolerance is an important mechanism in the mucosal immune system whereby oral administration of a specific antigen induces unresponsiveness of systemic immune responses with the same or different antigens (<xref ref-type="bibr" rid="bibr28-0192623311430693">Chen et al. 2007</xref>; <xref ref-type="bibr" rid="bibr174-0192623311430693">Weiner et al. 1994</xref>). TGF-β is critical for the induction of oral tolerance (<xref ref-type="bibr" rid="bibr28-0192623311430693">Chen et al. 2007</xref>; <xref ref-type="bibr" rid="bibr174-0192623311430693">Weiner et al. 1994</xref>). Low-dose of antigen cells leads to “dampening,” a paracrine effect, of the immune response due to TGF-β derived from nT<sub>REG</sub>, T<sub>H</sub>3, and T<sub>r</sub>1 cells. High-dose of an antigen is associated with mucosal T-cell anergy and apoptosis (<xref ref-type="bibr" rid="bibr28-0192623311430693">Chen et al. 2007</xref>; <xref ref-type="bibr" rid="bibr173-0192623311430693">Weiner 1997</xref>; <xref ref-type="bibr" rid="bibr174-0192623311430693">Weiner et al. 1994</xref>). At mucosal sites, T<sub>REG</sub> are responsible for “bystander” suppression, where TGF-β produced at mucosal sites during development of oral tolerance regulates immune responses on T-cells, B-cells, NK cells, macrophages, and dendritic cells in an antigen nonspecific manner (<xref ref-type="bibr" rid="bibr173-0192623311430693">Weiner 1997</xref>). Animal models of inflammatory bowel disease (IBD) have been used to study T<sub>REG</sub> and mucosal tolerance (<xref ref-type="bibr" rid="bibr21-0192623311430693">Blumberg 2009</xref>). Researchers have adoptively transferred CD4<sup>+</sup>CD45RB<sup>high </sup>T-cells into SCID or Rag-1 mice (<xref ref-type="bibr" rid="bibr121-0192623311430693">Powrie et al. 1994</xref>) or have relied on the 2, 4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodent model (<xref ref-type="bibr" rid="bibr156-0192623311430693">Te Velde et al. 2006</xref>). A negative effect of T<sub>REG</sub> in mucosal immunity is the secretion of TGF-β from T<sub>REG</sub> in the face of IL-6 and IL-21 in the inflammatory milieu. TGF-β can lead to differentiation of T<sub>H</sub>17 cells and subsequent inhibition of T<sub>REG</sub> differentiation, resulting in more severe inflammation (<xref ref-type="bibr" rid="bibr76-0192623311430693">Korn et al. 2009</xref>, <xref ref-type="bibr" rid="bibr75-0192623311430693">2007</xref>). T<sub>REG</sub> have a critical role in tolerance and “bystander” suppression of mucosal sites with resident γδ T-cells.</p>
</sec>
<sec id="section18-0192623311430693">
<title>Role of T<sub>REG</sub> in Inflammatory/Infectious Disease</title>
<p>Both natural and induced T<sub>REG</sub> are important in suppressing inflammation in infectious disease (<xref ref-type="fig" rid="fig15-0192623311430693">Figure 15</xref>; Abraham and Medhitzov 2011; <xref ref-type="bibr" rid="bibr91-0192623311430693">Liu et al. 2010</xref>; <xref ref-type="bibr" rid="bibr64-0192623311430693">Jager and Kuchroo 2010</xref>; <xref ref-type="bibr" rid="bibr138-0192623311430693">Scholzen et al. 2009</xref>; de Boer et al. 2007; <xref ref-type="bibr" rid="bibr14-0192623311430693">Belkaid and Rouse 2005</xref>). nT<sub>REG</sub> are activated by microbial infections and products of the resulting inflammatory milieu. T<sub>REG</sub> express toll-like receptors 4, 5, 7, and 8, allowing the cells to respond to bacterial products such as lipopolysaccharide leading to increased T<sub>REG</sub> survival and proliferation (<xref ref-type="bibr" rid="bibr25-0192623311430693">Caramahlo et al. 2003</xref>). Probiotics have been shown to elicit activation of T<sub>REG</sub>, which then suppress T<sub>H</sub>1-mediated colitis in the TNBS mouse colitis model (<xref ref-type="bibr" rid="bibr42-0192623311430693">Di Giacinto et al. 2005</xref>). Microbes are also able to manipulate antigen-presenting cells leading to priming/activation of T<sub>REG</sub> and elicit secretion of chemokines and cytokines that favor induction, priming, recruitment, and survival of T<sub>REG</sub>, thus using T<sub>REG </sub>for their own benefit (<xref ref-type="bibr" rid="bibr24-0192623311430693">Cabrera et al. 2004</xref>; <xref ref-type="bibr" rid="bibr58-0192623311430693">Hesse et al. 2004</xref>; <xref ref-type="bibr" rid="bibr25-0192623311430693">Caramahlo et al. 2003</xref>; <xref ref-type="bibr" rid="bibr13-0192623311430693">Belkaid et al. 2002</xref>). These microbial organisms include virus (HIV [<xref ref-type="bibr" rid="bibr1-0192623311430693">Aandahl et al. 2004</xref>], HCV [<xref ref-type="bibr" rid="bibr24-0192623311430693">Cabrera et al. 2004</xref>], CMV [<xref ref-type="bibr" rid="bibr1-0192623311430693">Aandahl et al. 2004</xref>], FIV [<xref ref-type="bibr" rid="bibr165-0192623311430693">Vahlenkamp et al. 2004</xref>], Herpes simplex virus [<xref ref-type="bibr" rid="bibr150-0192623311430693">Suvas et al. 2004</xref>]), bacteria (<italic>Helicobacter spp.</italic> [<xref ref-type="bibr" rid="bibr93-0192623311430693">Lundgren et al. 2003</xref>; <xref ref-type="bibr" rid="bibr79-0192623311430693">Kullberg et al. 2002</xref>] and <italic>Listeria monocytogenes </italic>[<xref ref-type="bibr" rid="bibr81-0192623311430693">Kursar et al. 2002</xref>]), fungi (<italic>Candida albicans</italic> [<xref ref-type="bibr" rid="bibr101-0192623311430693">Montagnoli et al. 2002</xref>] and <italic>Pneumocystis carinii </italic>[<xref ref-type="bibr" rid="bibr60-0192623311430693">Hori et al. 2002</xref>]), and protozoal (<italic>Leishmania major </italic>[<xref ref-type="bibr" rid="bibr13-0192623311430693">Belkaid et al. 2002</xref>], <italic>Schistosoma mansoni </italic>[<xref ref-type="bibr" rid="bibr58-0192623311430693">Hesse et al. 2004</xref>] and <italic>Plasmodium spp. </italic>[<xref ref-type="bibr" rid="bibr138-0192623311430693">Scholzen et al. 2009</xref>]). T<sub>REG</sub> can become infected with viral pathogens (e.g., HIV and FIV), and it is uncertain if they remain suppressive when infected (<xref ref-type="bibr" rid="bibr68-0192623311430693">Joshi et al. 2004</xref>; <xref ref-type="bibr" rid="bibr117-0192623311430693">Oswald-Richter et al. 2004</xref>). Animal infection models and infected humans show accumulation of T<sub>REG</sub> at the site of infection with leishmaniasis, herpes simplex virus, and schistosomiasis (<xref ref-type="bibr" rid="bibr58-0192623311430693">Hesse et al. 2004</xref>; <xref ref-type="bibr" rid="bibr150-0192623311430693">Suvas et al. 2004</xref>; <xref ref-type="bibr" rid="bibr13-0192623311430693">Belkaid et al. 2002</xref>), in the peripheral blood with HIV and HCV (<xref ref-type="bibr" rid="bibr117-0192623311430693">Oswald-Richter et al. 2004</xref>) and in lymphoid organs of HIV patients (<xref ref-type="bibr" rid="bibr6-0192623311430693">Andersson et al. 2005</xref>). A good example of the role of T<sub>REG</sub> in infection would be <italic>Plasmodium spp. </italic>that causes malaria in human patients and rodent models and is associated with increased numbers of T<sub>REG</sub> (i.e., natural and induced), which have a direct association with the parasitic load in the host. T<sub>REG</sub> accumulate in areas of inflammation induced by the organisms and inhibit T<sub>H</sub>1 responses (i.e., both protective and pathologic) primarily by the suppressive effects of IL-10 and TGF-β, and ultimately result in either clearance of the organism and resolution or clinical cases of malaria depending on the level of T<sub>REG</sub> cell induction and the organism’s manipulation of this lymphocyte population (<xref ref-type="bibr" rid="bibr138-0192623311430693">Scholzen et al. 2009</xref>). T<sub>REG</sub> has also been shown to be a factor in the development of silica-induced pulmonary fibrosis in a mouse model. Depletion of T<sub>REG</sub> leads to the maintenance of a T<sub>H</sub>1 response and subsequent attenuation of fibrosis versus the shift to a T<sub>H</sub>2 response that normally predisposes to development of fibrosis in this model (<xref ref-type="bibr" rid="bibr91-0192623311430693">Liu et al. 2010</xref>). The balance between effector T-cells and T<sub>REG</sub> is critical in determining the immune response to pathogens (<xref ref-type="fig" rid="fig16-0192623311430693">Figure 16</xref>).</p>
<fig id="fig15-0192623311430693" position="float">
<label>Figure 15.</label>
<caption>
<p>During an infection with a pathogenic organism complex networks develop where nT<sub>REG</sub> undergo antigen-specific expansion and T<sub>r</sub>1 and iT<sub>REG</sub> cells undergo pathogen-specific differentiation in the presence of tolerogenic cytokines (IL-10 and TGF-β). All three types of T<sub>REG</sub> cells then work to suppress effector T-cells in the inflammatory milieu by soluble factors, cell-to-cell contact, or competing for IL-2. nT<sub>REG</sub> can also induce infectious tolerance in dendritic cells. Together these result in suppression of immune responses to pathogens. Pathogens can also use T<sub>REG</sub> for their own benefit to evade the immune response.</p>
</caption>
<graphic alternate-form-of="fig15-0192623311430693" xlink:href="10.1177_0192623311430693-fig15.tif"/>
</fig>
<fig id="fig16-0192623311430693" position="float">
<label>Figure 16.</label>
<caption>
<p>The balance between effector cells and T<sub>REG</sub> cells in the inflammatory milieu dictate the course of and ultimate resolution or persistence of the inflammatory response to an infectious agent. There are advantages and disadvantages for both the host and microbe if there is an imbalance in the numbers/function of effector cells and T<sub>REG</sub>.</p>
</caption>
<graphic alternate-form-of="fig16-0192623311430693" xlink:href="10.1177_0192623311430693-fig16.tif"/>
</fig>
</sec>
<sec id="section19-0192623311430693">
<title>Role of T<sub>REG</sub> in Organ Transplantation</title>
<p>T<sub>REG</sub> have been shown to have a pivotal role in transplant tolerance leading to graft acceptance and prevention of rejection in xenotransplantation (<xref ref-type="bibr" rid="bibr104-0192623311430693">Muller et al. 2009</xref>; <xref ref-type="bibr" rid="bibr185-0192623311430693">Zhang et al. 2009</xref>; <xref ref-type="bibr" rid="bibr83-0192623311430693">Le and Chao 2007</xref>; <xref ref-type="bibr" rid="bibr183-0192623311430693">Yong et al. 2007</xref>). Adoptive transfer of T<sub>REG</sub> into mice has been shown to inhibit, delay, and prevent development of graft versus host disease (GVHD) (<xref ref-type="bibr" rid="bibr155-0192623311430693">Taylor et al. 2002</xref>; <xref ref-type="bibr" rid="bibr32-0192623311430693">Cohen et al. 2002</xref>) as well as to prevent allograft (i.e., pancreatic islet cell transplant) rejection (<xref ref-type="bibr" rid="bibr11-0192623311430693">Battaglia et al. 2006</xref>; <xref ref-type="bibr" rid="bibr52-0192623311430693">Gregori et al. 2001</xref>). Post-transplant immunosuppressive drugs have been shown to have variable effects on T<sub>REG</sub>. Mycophenolate mofetil increases T<sub>REG</sub> numbers and induces transplant tolerance when given with vitamin D (<xref ref-type="bibr" rid="bibr56-0192623311430693">Han et al. 2005</xref>; <xref ref-type="bibr" rid="bibr62-0192623311430693">Huang et al. 2003</xref>; <xref ref-type="bibr" rid="bibr52-0192623311430693">Gregori et al. 2001</xref>), calcineurin inhibitors (e.g., cyclosporine, tacrolimus, sirolimus) decrease T<sub>REG</sub> and abrogate transplant tolerance (<xref ref-type="bibr" rid="bibr145-0192623311430693">Shoji et al. 2005</xref>; <xref ref-type="bibr" rid="bibr82-0192623311430693">Larsen et al. 1996</xref>), and Rapamycin and methylprednisolone do not seem to have effects on T<sub>REG</sub> or transplant tolerance (<xref ref-type="bibr" rid="bibr18-0192623311430693">Blaha et al. 2003</xref>).</p>
</sec>
<sec id="section20-0192623311430693">
<title>Role of T<sub>REG </sub>in Pregnancy</title>
<p>Natural T<sub>REG</sub>, CD8<sup>+</sup> T<sub>REG</sub>, T<sub>H</sub>3 cells, and T<sub>r</sub>1 cells have been shown to be important in immune tolerance during pregnancy (<xref ref-type="bibr" rid="bibr55-0192623311430693">Guerin et al. 2009</xref>; <xref ref-type="bibr" rid="bibr162-0192623311430693">Trowsdale and Betz 2006</xref>; <xref ref-type="bibr" rid="bibr5-0192623311430693">Aluvihare et al. 2004</xref>). IL-2/STAT5 signaling and 17-β-estradiol (E2) during pregnancy cause induction of FOXP3 and increased T<sub>REG</sub> numbers (i.e., humans and animal models) by induction of FOXP3+ iT<sub>REG</sub> and T<sub>REG</sub> cell expansion (<xref ref-type="bibr" rid="bibr44-0192623311430693">Fainboim and Arruvito 2011</xref>). Fetal alloantigen (<xref ref-type="bibr" rid="bibr187-0192623311430693">Zhao et al. 2007</xref>) and placental trophoblast antigens such as heat shock protein-60, carcinoembryonic antigen, CD274 (i.e., ligand for programmed cell death-1 receptor), and human leukocyte antigen-G (<xref ref-type="bibr" rid="bibr151-0192623311430693">Taglauer et al. 2008</xref>; <xref ref-type="bibr" rid="bibr182-0192623311430693">Yang et al. 2006</xref>; <xref ref-type="bibr" rid="bibr143-0192623311430693">Shao et al. 2005</xref>; <xref ref-type="bibr" rid="bibr85-0192623311430693">LeMaoult et al. 2004</xref>) are also important in T<sub>REG</sub> cell induction/activation and expansion during early pregnancy. Paternal alloantigens and TGF-β in seminal fluid can also induce/activate T<sub>REG</sub> (<xref ref-type="bibr" rid="bibr126-0192623311430693">Robertson et al. 2009</xref>; <xref ref-type="bibr" rid="bibr127-0192623311430693">Robertson and Sharkey 2001</xref>). During the course of pregnancy, there are increased numbers of CD4<sup>+</sup>CD25<sup>+</sup> cells in the circulation in early pregnancy, reaching an apex during the second trimester and declining until the postpartum period where they reach a number that is nearly at the prepregnancy level (<xref ref-type="bibr" rid="bibr57-0192623311430693">Heikkinen et al. 2004</xref>). T<sub>REG</sub> are significantly decreased in deciduas from spontaneous vaginal deliveries when compared with Caesarean section, indicating a potential role of declining T<sub>REG</sub> in fetal delivery (<xref ref-type="bibr" rid="bibr179-0192623311430693">Xhao et al. 2007</xref>; <xref ref-type="bibr" rid="bibr148-0192623311430693">Sindram-Trujillo et al. 2004</xref>). The ovary normally contains a population of thymic-derived nT<sub>REG </sub>(<xref ref-type="bibr" rid="bibr135-0192623311430693">Samy et al. 2005</xref>), and the testis has been shown to have a locally induced iT<sub>REG</sub> population that are specifically targeted to testicular antigens and contributes to testicular immune privilege (<xref ref-type="bibr" rid="bibr108-0192623311430693">Nasr et al. 2005</xref>). T<sub>REG</sub> have been shown to be necessary for immune tolerance of the conceptus, oocytes, and spermatozoa (<xref ref-type="bibr" rid="bibr162-0192623311430693">Trowsdale and Betz 2006</xref>). There are increased numbers of T<sub>REG</sub> in the blood, decidual tissue, and lymph nodes draining the uterus (<xref ref-type="bibr" rid="bibr160-0192623311430693">Tilburgs et al. 2008</xref>; <xref ref-type="bibr" rid="bibr158-0192623311430693">Thuere et al. 2007</xref>). T<sub>REG</sub> cell depletion and/or decreased function have been shown to lead to loss of pregnancy in rodent models (<xref ref-type="bibr" rid="bibr5-0192623311430693">Aluvihare et al. 2004</xref>) and in patients who have miscarried (<xref ref-type="bibr" rid="bibr181-0192623311430693">Yang et al. 2008</xref>; <xref ref-type="bibr" rid="bibr137-0192623311430693">Sasaki et al. 2004</xref>). Infertility, miscarriage, and pre-eclampsia have been linked with decreased T<sub>REG</sub> number and/or function (<xref ref-type="bibr" rid="bibr55-0192623311430693">Guerin et al. 2009</xref>; <xref ref-type="bibr" rid="bibr160-0192623311430693">Tilburgs et al. 2008</xref>; <xref ref-type="bibr" rid="bibr158-0192623311430693">Thuere et al. 2007</xref>; <xref ref-type="bibr" rid="bibr162-0192623311430693">Trowsdale and Betz 2006</xref>; <xref ref-type="bibr" rid="bibr5-0192623311430693">Aluvihare et al. 2004</xref>).</p>
</sec>
<sec id="section21-0192623311430693">
<title>Role of T<sub>REG</sub> in Cancer</title>
<p>T<sub>REG</sub> have been shown to dampen the cytotoxic immune response (CD8+/NK cell) as well as suppressing overall level of host immune response to the neoplasm in cancer. Researchers have looked at numbers and location of T<sub>REG</sub> and the effects on cancer patient outcome (<xref ref-type="bibr" rid="bibr98-0192623311430693">Menetrier-Caux et al. 2009</xref>). They showed that T<sub>REG</sub> are present in a large panel of solid tumors in humans. T<sub>REG</sub> in pulmonary, pancreatic, gastric, hepatic, and ovarian carcinomas have been correlated with a negative outcome; while in B-cell lymphoma, head and neck cancer and colonic carcinoma T<sub>REG</sub> have been associated with a positive patient outcome (<xref ref-type="bibr" rid="bibr98-0192623311430693">Menetrier-Caux et al. 2009</xref>). T<sub>REG</sub> had no effect on survival with prostatic, renal, and squamous cell carcinomas (<xref ref-type="bibr" rid="bibr98-0192623311430693">Menetrier-Caux et al. 2009</xref>). In breast cancer, T<sub>REG</sub> in peri-tumoral lymphoid aggregates were correlated with a negative outcome, while intra-tumoral T<sub>REG</sub> were associated with a positive outcome. (<xref ref-type="bibr" rid="bibr98-0192623311430693">Menetrier-Caux et al. 2009</xref>) The results of vaccine-induced cancer T-cell mediated immunotherapy (i.e., cancer vaccine therapy) have proven to be disappointing (<xref ref-type="bibr" rid="bibr175-0192623311430693">Welters et al. 2008</xref>) due to the vaccine’s inability to induce effector T-cells, T<sub>REG</sub> already present in the tumor, and/or induction of T<sub>REG</sub> by the vaccine itself. Based on these findings, the success of cancer vaccine therapy will depend on the balance between T<sub>REG</sub> and effector cells at the start of therapy (<xref ref-type="bibr" rid="bibr175-0192623311430693">Welters et al. 2008</xref>). Neoplastic T<sub>REG</sub> cells in Sézary Syndrome (leukemic variant of cutaneous T-cell lymphoma in the human) express variant splices of FOXP3. The neoplastic cells with variant FOXP3 are able to function as T<sub>REG</sub> and work to dampen the host immune response against the neoplastic T-lymphocytes (<xref ref-type="bibr" rid="bibr77-0192623311430693">Krejsgaard et al. 2008</xref>).</p>
</sec>
<sec id="section22-0192623311430693">
<title>T<sub>REG</sub> as a Modulatory Target in Drug Development</title>
<p>Pharmacological agents have been developed that control T<sub>REG</sub> number and/or function (<xref ref-type="bibr" rid="bibr114-0192623311430693">Ohkura et al. 2011</xref>; <xref ref-type="bibr" rid="bibr111-0192623311430693">Nizar et al. 2010</xref>; <xref ref-type="bibr" rid="bibr157-0192623311430693">Thorburn and Hansbro 2010</xref>; <xref ref-type="bibr" rid="bibr107-0192623311430693">Nandakumar et al. 2009</xref>; <xref ref-type="bibr" rid="bibr154-0192623311430693">Tao et al. 2007</xref>; <xref ref-type="bibr" rid="bibr182-0192623311430693">Yang et al. 2006</xref>). Molecules that increase T<sub>REG</sub> number include rTGF-β, FTY720 (Fingolimod, a S1P1 modulator), retinoic acids, histone deacetylase inhibitors, and probiotics. T<sub>REG</sub> suppressive function is augmented with the following agents: recombinant IL-2, Rapamycin (mTOR pathway inhibitor) in type-1-diabetes mellitus and renal transplantation, and histone deacetylase inhibitors. Histone deacetylase inhibitors that are also known as chromatin modifying agents (e.g., HDAC9) lead to increased T<sub>REG</sub> number and function by a combination of FOXP3 protein acetylation, T<sub>REG</sub> chromatin remodeling, and promotion of T<sub>REG</sub> development (<xref ref-type="bibr" rid="bibr154-0192623311430693">Tao et al. 2007</xref>). While agents that block the TGF-β and/or CTLA-4 signaling pathways decrease T<sub>REG </sub>number and/or function. Aromatase inhibitors (e.g., Letrozole) used for estrogen modulation in cancer chemotherapy regimens and recombinant IL-2 lead to decreased T<sub>REG</sub> numbers.</p>
<p>Biopharmaceutical agents have been developed to modulate T<sub>REG</sub> (<xref ref-type="bibr" rid="bibr74-0192623311430693">Khan et al. 2011</xref>; <xref ref-type="bibr" rid="bibr114-0192623311430693">Ohkura et al. 2011</xref>; <xref ref-type="bibr" rid="bibr40-0192623311430693">De Serres et al. 2011</xref>; <xref ref-type="bibr" rid="bibr172-0192623311430693">Weber et al. 2009</xref>) including Tremelimumab (CTLA-4 modulation) in advanced melanoma which leads to increased effector T-cell numbers with no change in T<sub>REG</sub> number, CD25 modulation by Daclizumab in multiple sclerosis (MS) and advanced breast cancer, Denileukin diftitox as a cancer vaccine, LMB-2 and RFT5-SMPY-dgA in advanced melanoma decrease T<sub>REG </sub>number, anti-GITR MoAb (DTA1) which leads to decreased T<sub>REG</sub> number, agonist anti-OX40 MoAb (OX86) and anti-FR4 MoAb which decrease T<sub>REG</sub> number, and Alemtuzumab (anti-CD52 MoAb) which increases T<sub>REG</sub> number.</p>
<p>Adoptive transfer of T<sub>REG</sub> has been evaluated in clinical trials of patients that have received human stem cell transplants to induce transplant tolerance, patients with GVHD, and type 1 diabetes mellitus patients to ameliorate autoimmune disease with a good patient safety profile and showed that the procedure is feasible, yet efficacy still needs to be shown convincingly (<xref ref-type="bibr" rid="bibr125-0192623311430693">Riley et al. 2009</xref>; <xref ref-type="bibr" rid="bibr163-0192623311430693">Trzonkowski et al. 2009</xref>).</p>
</sec>
<sec id="section23-0192623311430693">
<title>Conclusions</title>
<p>T<sub>REG</sub> have both positive and negative functions in the immune system. Positive aspects of T<sub>REG</sub> include suppression of immune responses including autoimmunity, maintaining immune homeostasis, as well as tolerance in xenotransplantation, at mucosal sites, and during pregnancy. Negative aspects of T<sub>REG</sub> can include manipulation by some infectious agents to avoid the host’s immune response and in cancer T<sub>REG</sub> can suppress the body’s cytotoxic immune response to neoplastic cells. The balance between T<sub>REG</sub> and effector cells determines the fate of an immune response. The fact that the immune system has so many sources of regulatory cells which overlap functionally but have slightly different induction/activation pathways underscores the importance of T<sub>REG </sub>in host survival.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0192623311430693">
<p>The author declared no potential conflicts of interests with respect to the authorship and/or publication of this article. The author received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<glossary content-type="abbr">
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="term1-0192623311430693">A<sub>2A</sub></term>
<def>
<p>adenosine receptor</p>
</def>
</def-item>
<def-item>
<term id="term2-0192623311430693">APC</term>
<def>
<p>antigen presenting cell</p>
</def>
</def-item>
<def-item>
<term id="term3-0192623311430693">B<sub>REG</sub></term>
<def>
<p>regulatory B-cell</p>
</def>
</def-item>
<def-item>
<term id="term4-0192623311430693">CD</term>
<def>
<p>cluster of differentiation</p>
</def>
</def-item>
<def-item>
<term id="term5-0192623311430693">CMV</term>
<def>
<p>cytomegalovirus</p>
</def>
</def-item>
<def-item>
<term id="term6-0192623311430693">CTLA-4</term>
<def>
<p>cytotoxic T-lymphocyte antigen-4</p>
</def>
</def-item>
<def-item>
<term id="term7-0192623311430693">DN</term>
<def>
<p>double negative</p>
</def>
</def-item>
<def-item>
<term id="term8-0192623311430693">DTH</term>
<def>
<p>delayed-type hypersensitivity</p>
</def>
</def-item>
<def-item>
<term id="term9-0192623311430693">EAE</term>
<def>
<p>experimental autoimmune encephalomyelitis</p>
</def>
</def-item>
<def-item>
<term id="term10-0192623311430693">FIV</term>
<def>
<p>feline immunodeficiency virus</p>
</def>
</def-item>
<def-item>
<term id="term11-0192623311430693">FLG-2</term>
<def>
<p>fibrinogen-like protein-2</p>
</def>
</def-item>
<def-item>
<term id="term12-0192623311430693">FOXP3</term>
<def>
<p>forkhead box protein-3</p>
</def>
</def-item>
<def-item>
<term id="term13-0192623311430693">GVHD</term>
<def>
<p>graft-versus-host disease</p>
</def>
</def-item>
<def-item>
<term id="term14-0192623311430693">HCV</term>
<def>
<p>hepatitis C virus</p>
</def>
</def-item><def-item>
<term id="term15-0192623311430693">HIV</term>
<def>
<p>human immunodeficiency virus</p>
</def>
</def-item><def-item>
<term id="term16-0192623311430693">IBD</term>
<def>
<p>inflammatory bowel disease</p>
</def>
</def-item><def-item>
<term id="term17-0192623311430693">IFNγ</term>
<def>
<p>interferon gamma</p>
</def>
</def-item><def-item>
<term id="term18-0192623311430693">IL</term>
<def>
<p>interleukin</p>
</def>
</def-item><def-item>
<term id="term19-0192623311430693">IPEX</term>
<def>
<p>immunodysregulation polyendocrinopathy enteropathy X-linked syndrome</p>
</def>
</def-item><def-item>
<term id="term20-0192623311430693">LAG3</term>
<def>
<p>lymphocyte-activating gene-3</p>
</def>
</def-item><def-item>
<term id="term21-0192623311430693">MHC</term>
<def>
<p>major histocompatability complex</p>
</def>
</def-item><def-item>
<term id="term22-0192623311430693">miR</term>
<def>
<p>microRNA</p>
</def>
</def-item>
<def-item>
<term id="term23-0192623311430693">MoAb</term>
<def>
<p>monoclonal antibody</p>
</def>
</def-item>
<def-item>
<term id="term24-0192623311430693">mTOR</term>
<def>
<p>mammalian target of rapamycin</p>
</def>
</def-item>
<def-item>
<term id="term25-0192623311430693">NK cell</term>
<def>
<p>natural killer cell</p>
</def>
</def-item><def-item>
<term id="term26-0192623311430693">NKT<sub>REG</sub></term>
<def>
<p>natural killer regulatory T-cell</p>
</def>
</def-item><def-item>
<term id="term27-0192623311430693">SCID</term>
<def>
<p>severe combined immunodeficient</p>
</def>
</def-item><def-item>
<term id="term28-0192623311430693">TCR</term>
<def>
<p>T-cell receptor</p>
</def>
</def-item><def-item>
<term id="term29-0192623311430693">TGF-β</term>
<def>
<p>transforming growth factor beta</p>
</def>
</def-item><def-item>
<term id="term30-0192623311430693">T<sub>H</sub>0</term>
<def>
<p>T-helper 0 cell</p>
</def>
</def-item><def-item>
<term id="term31-0192623311430693">T<sub>H</sub>1</term>
<def>
<p>T-helper 1 cell</p>
</def>
</def-item><def-item>
<term id="term32-0192623311430693">T<sub>H</sub>2</term>
<def>
<p>T-helper 2 cell</p>
</def>
</def-item><def-item>
<term id="term33-0192623311430693">T<sub>H</sub>3</term>
<def>
<p>T-helper 3 cell</p>
</def>
</def-item><def-item>
<term id="term34-0192623311430693">T<sub>H</sub>17</term>
<def>
<p>T-helper 17 cell</p>
</def>
</def-item><def-item>
<term id="term35-0192623311430693">T<sub>REG</sub></term>
<def>
<p>regulatory T-cell</p>
</def>
</def-item><def-item>
<term id="term36-0192623311430693">T<sub>r</sub>1</term>
<def>
<p>type 1 regulatory T-cells</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgments</title>
<p>I would like to acknowledge the following researchers: Virginia Godfrey, DVM, PhD, DACVP, from the University of North Carolina at Chapel Hill for her kind donation of the “Scurfy” mouse images; Caroline Genell from the GlaxoSmithKline, Safety Assessment, Immunotoxicology Group for the rat T<sub>REG</sub> flow cytometry data; and John Spaull of the GlaxoSmithKline MCT Cell Biology Group for the FOXP3 immunofluorescence images.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="bibr1-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aandahl</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Michaelsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moretto</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Nixon</surname>
<given-names>D. F.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Human CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells control T-cell responses to Human Immunodeficiency Virus and Cytomegalovirus antigens</article-title>. <source>J Virol</source> <volume>78</volume>, <fpage>2454</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr2-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Interleukin-23/T<sub>H</sub> 17 pathways and inflammatory bowel disease</article-title>. <source>Inflamm Bowel Dis</source> <volume>15</volume>(<issue>7</issue>), <fpage>1090</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr3-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Medzhitov</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Interactions between the host innate immune system and microbes in inflammatory bowel disease</article-title>. <source>Gastroenterol</source> <volume>140</volume>, <fpage>1729</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr4-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akdis</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Immune tolerance in allergy</article-title>. <source>Curr Opin Immunol</source> <volume>21</volume>, <fpage>700</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr5-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aluvihare</surname>
<given-names>V. R.</given-names>
</name>
<name>
<surname>Kallikourdis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Betz</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Regulatory T cells mediate maternal tolerance to the fetus</article-title>. <source>Nat Immunol</source> <volume>5</volume>, <fpage>266</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr6-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boasso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shire</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Lindback</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shearer</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Chougnet</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Cutting edge: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients</article-title>. <source>J Immunol</source> <volume>174</volume>(<issue>6</issue>), <fpage>3143</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr7-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Annacker</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Asseman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Powrie</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Interleukin-10 in the regulation of T cell-induced colitis</article-title>. <source>J Autoimmun</source> <volume>20</volume>, <fpage>277</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr8-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Askenasy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kaminitz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yarkoni</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Mechanisms of T regulatory cell function</article-title>. <source>Autoimmunity Rev</source> <volume>7</volume>, <fpage>370</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr9-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanackovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Brunner-Weinzieri</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Kroger</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Serke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deter</surname>
<given-names>H. C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Acute physiological stress simultaneously alters hormone levels, recruitment of lymphocyte subsets, and production of reactive oxygen species</article-title>. <source>Immunol Invest</source> <volume>31</volume>(<issue>2</issue>), <fpage>73</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr10-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanackovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schnee</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schuch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Faltz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Schafhausen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bartels</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bokermeyer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brunner-Weinzieri</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Deter</surname>
<given-names>H. C.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Acute physiological stress alerts the adaptive immune response: stress-induced mobilization of effector T cells</article-title>. <source>J Neuroimmunol</source> <volume>176</volume>, <fpage>141</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr11-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Battaglia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stabilini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Migliavacca</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Horejs-Hoeck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaupper</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Roncarolo</surname>
<given-names>M. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Rapamycin promotes expansion of functional CD4<sup>+</sup>CD25<sup>+</sup>FOXP<sup>+</sup> regulatory T cells of both healthy subjects and type 1 diabetic patients</article-title>. <source>J Immunol</source> <volume>177</volume>(<issue>12</issue>), <fpage>8338</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr12-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beissert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Regulatory T cells</article-title>. <source>J Invest Dermatol</source> <volume>126</volume>, <fpage>15</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr13-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Piccirillo</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Mendez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shevack</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sacks</surname>
<given-names>D. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells control <italic>Leishmania</italic> <italic>major</italic> persistence and immunity</article-title>. <source>Nature</source> <volume>420</volume>, <fpage>502</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr14-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rouse</surname>
<given-names>B. T.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Natural regulatory T cells in infectious disease</article-title>. <source>Nature Immunol</source> <volume>6</volume>(<issue>4</issue>), <fpage>353</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr15-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bettelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Carrier</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Strom</surname>
<given-names>T. B.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Reciprocal developmental pathways for the generation of pathogenic effector T<sub>H</sub> 17 and regulatory T cells</article-title>. <source>Nature</source> <volume>441</volume>, <fpage>235</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr16-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bienvenu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Auffray</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cordier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Becourt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Peripheral CD8<sup>+</sup>CD25<sup>+</sup> T lymphocytes from MHC class II-deficient mice exhibit regulatory activity</article-title>. <source>J Immunol</source> <volume>175</volume>, <fpage>246</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr17-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biros</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Anterior chamber-associated immune deviation</article-title>. <source>Vet Clin Small Anim</source> <volume>38</volume>, <fpage>309</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr18-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bigenzahn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koporc</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Scmid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Selzer</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade</article-title>. <source>Blood</source> <volume>101</volume>(<issue>7</issue>), <fpage>2886</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr19-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloom</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells in nonhuman primates</article-title>. <source>Transplant Rev</source> <volume>20</volume>, <fpage>121</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr20-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bluestone</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>How do CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells control autoimmunity?</article-title> <source>Curr Opin Immunol</source> <volume>17</volume>, <fpage>638</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr21-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blumberg</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Inflammation in the intestinal tract: Pathogenesis and treatment</article-title>. <source>Dig Dis</source> <volume>27</volume>, <fpage>455</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr22-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brossay</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tangri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bix</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cardell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Locksley</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Kronenberg</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1<sup>+</sup> targets</article-title>. <source>J Immunol</source> <volume>160</volume>, <fpage>3681</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr23-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunkow</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Jeffery</surname>
<given-names>E. W.</given-names>
</name>
<name>
<surname>Hjerrild</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Paeper</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Yasayko</surname>
<given-names>S.-A.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Galas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Ramsdell</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Disruption of a new forkhead/winged helix protein, scurfin, results in the fatal lymphoproliferative disorder of the Scurfy mouse</article-title>. <source>Nat Genetics</source> <volume>27</volume>, <fpage>68</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr24-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabrera</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Firpi</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>An immunomodulatory role for CD4<sup>+</sup>CD25<sup>+</sup> regulatory T lymphocytes in Hepatitis C Virus infection</article-title>. <source>Hepatology</source> <volume>40</volume>, <fpage>1062</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr25-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caramahlo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lopes-Carvahlo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ostler</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zelenay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Haury</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Demengeot</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Regulatory T cells selectively express Toll-Like Receptors and are activated by lipolysaccharide</article-title>. <source>J Exp Med</source> <volume>197</volume>, <fpage>403</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr26-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Ciubotariu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Manavalan</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Tolerization of dendritic cells by T(s) cells: The crucial role of inhibitory receptors ILT3 and ILT4</article-title>. <source>Nature Immunol</source> <volume>3</volume>, <fpage>237</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr27-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Role of double-negative regulatory T cells in long-term cardiax xenograft survival</article-title>. <source>J Immunol</source> <volume>170</volume>, <fpage>1846</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr28-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Perruche</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>CD4<sup>+</sup>CD25<sup>+</sup> T regulatory cells and TGF-β in mucosal immune system: The good and the bad</article-title>. <source>Curr Medicinal Chem</source> <volume>14</volume>, <fpage>2245</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr29-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Torrealba</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells</article-title>. <source>J Immunol</source> <volume>175</volume>, <fpage>3409</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr30-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claman</surname>
<given-names>H. N.</given-names>
</name>
<name>
<surname>Chaperon</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Triplett</surname>
<given-names>R. F.</given-names>
</name>
</person-group> (<year>1966</year>). <article-title>Thymus-marrow cell combinations. Synergism in antibody production</article-title>. <source>Proc Soc Exp Biol Med</source> <volume>122</volume>, <fpage>1167</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr31-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Appleby</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Brunkow</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Ramsdell</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Cellular and molecular characterization of the <italic>Scurfy</italic> mouse mutant</article-title>. <source>J Immunol</source> <volume>162</volume>, <fpage>2546</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr32-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Trenado</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vasey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Klatzmann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>B. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>CD4+CD25+ immunoregulatory T cells: New therapeutics for graft-versus-host disease</article-title>. <source>J Exp Med</source> <volume>196</volume>, <fpage>401</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr33-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cortesini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>LeMaoult</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ciubotariu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suciu Foca Cortesini</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>CD8<sup>+</sup>CD28<sup>−</sup> T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of T<sub>H</sub> reactivity</article-title>. <source>Immunol Rev</source> <volume>182</volume>, <fpage>201</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr34-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coutinho</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caramalho</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Seixas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Demengeot</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection</article-title>. <source>Curr Top Microbiol Immunol</source> <volume>293</volume>, <fpage>43</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr35-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crome</surname>
<given-names>S. Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Levings</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Translational mini-review series on T <sub>H</sub> 17 cells: Function and regulation of human T helper 17 cells in health and disease</article-title>. <source>Clin Exp Immunol</source> <volume>159</volume>, <fpage>109</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr36-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cupedo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weijer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Spits</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Development and activation of regulatory T cells in the human fetus</article-title>. <source>Eur J Immunol</source> <volume>35</volume>, <fpage>383</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr37-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Datta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sarvetnick</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Lymphocyte proliferation in immune-mediated diseases</article-title>. <source>Trends Immunol</source> <volume>30</volume>(<issue>9</issue>), <fpage>430</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr38-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deaglio</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression</article-title>. <source>J Exp Med</source> <volume>204</volume>, <fpage>1257</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr39-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Boer</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>van der Loos</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Teeling</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>van der Wal</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Teunissen</surname>
<given-names>M. B. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Immunohistocehmical analysis of regulatory T cell markers FOXP3 and GITR on CD4<sup>+</sup>CD25<sup>+</sup> T cells in normal skin and inflammatory dermatoses</article-title>. <source>J Histochem and Cytochem</source> <volume>55</volume>(<issue>9</issue>), <fpage>891</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr40-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Serres</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Mfarrej</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Najafian</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Effect of biologic agents on regulatory T cells</article-title>. <source>Transplantation Rev</source> <volume>25</volume>(<issue>3</issue>), <fpage>110</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr41-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Engle</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile Encephalitis Virus</article-title>. <source>J Virol</source> <volume>77</volume>(<issue>4</issue>), <fpage>2578</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr42-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Giacinto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marinaro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Strober</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Boirivant</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Probiotics ameliorate recurrent T<sub>H</sub> 1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells</article-title>. <source>J Immunol</source> <volume>174</volume>, <fpage>3237</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr43-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dittel</surname>
<given-names>B. N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS</article-title>. <source>Brain, Behavior, and Immunity</source> <volume>22</volume>, <fpage>421</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr44-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fainboim</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Arruvito</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Mechanisms involved in the expansion of T<sub>REG</sub> during pregnancy: role of IL-2/STAT5 signalling</article-title>. <source>Journal of Repro Immunol</source> <volume>88</volume>, <fpage>93</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr45-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontenot</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Gavin</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Rudensky</surname>
<given-names>A. Y.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>FOXP3 programs the development and function of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cells</article-title>. <source>Nat Immunol</source> <volume>4</volume>, <fpage>330</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr46-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontenot</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Rudensky</surname>
<given-names>A. Y.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor FOXP3</article-title>. <source>Nature Immunol</source> <volume>6</volume>(<issue>4</issue>), <fpage>331</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr47-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freir</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Nowottne</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bartels</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hildebrandt</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luetkens</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pabst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Muzzulini</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schnee</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Brunner-Weinzieri</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Marangalo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bokemeyer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Deter</surname>
<given-names>H.-C.</given-names>
</name>
<name>
<surname>Atanackovic</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Decrease of CD4<sup>+</sup>FOXP3<sup>+</sup> T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor</article-title>. <source>Psychoneuroendocrinol</source> <volume>35</volume>, <fpage>663</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr48-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujio</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The family of IL-10-secreting CD4<sup>+ </sup>T cells</article-title>. <source>Advances in Immunology</source> <volume>105</volume>, <fpage>99</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr49-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garin</surname>
<given-names>M. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Galectin-1: A key effector of regulation mediated by CD4<sup>+</sup>CD25<sup>+</sup> T cells</article-title>. <source>Blood</source> <volume>109</volume>, <fpage>2058</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr50-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Germain</surname>
<given-names>R. N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Special regulatory T cell review: A rose by any other name: from suppressor T cells to T<sub>REG</sub>, approbation to unbridled enthusiasm</article-title>. <source>Immunol</source> <volume>123</volume>, <fpage>20</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr51-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godfrey</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>L. B.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>X-linked lymphoreticular disease in the Scurfy (sf) mutant mouse</article-title>. <source>Am J Pathol</source> <volume>138</volume>(<issue>6</issue>), <fpage>1379</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr52-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Casorati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amuchastegui</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Smiroldo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Davalli</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Adorini</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Regulatory T cells induced by 1-Alpha-25-Dihydroxyvitamin D3 and Mycophenolate Mofetil treatment mediate transplantation tolerance</article-title>. <source>J Immunol</source> <volume>167</volume>(<issue>4</issue>), <fpage>1945</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr53-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greshon</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>Infectious immunological tolerance</article-title>. <source>Immunology</source> <volume>21</volume>, <fpage>903</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr54-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grossman</surname>
<given-names>W. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Differential expression of Granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells</article-title>. <source>Blood</source> <volume>104</volume>, <fpage>2840</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr55-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerin</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Prins</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Regulatory T-cells and immune tolerance in pregnancy: A new target for infertility treatment?</article-title> <source>Human Repro Update</source> <volume>15</volume>(<issue>5</issue>), <fpage>517</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr56-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The influence of Mycophenolate Mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients</article-title>. <source>Zhonghua YiXue ZaZhi</source> <volume>85</volume>(<issue>19</issue>), <fpage>1327</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr57-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heikkinen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mottonen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alanen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lassila</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Phenotypic characterization of regulatory T cells in the human decidua</article-title>. <source>Clin Exp Immunol</source> <volume>136</volume>, <fpage>373</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr58-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hesse</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piccirillo</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Belkaid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Prufer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mentink-Kane</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leusink</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cheever</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Wynn</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells</article-title>. <source>J Immunol</source> <volume>172</volume>, <fpage>3157</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr59-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hezova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Slaby</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Faltejskova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mikulkova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Buresova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Muthu Raja</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Hodek</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ovesna</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Michalek</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>MicroRNA-342, microRNA-191, and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients</article-title>. <source>Cellular Immunol</source> <volume>260</volume>, <fpage>70</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr60-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carvahlo</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Demengeot</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>CD25<sup>+</sup>CD4<sup>+</sup> regulatory T cells suppress CD4<sup>+</sup> T cell-mediated pulmonary hyperinflammation driven by <italic>Pneumocystis carinii</italic> in immunodeficient mice</article-title>. <source>Eur J Immunol</source> <volume>32</volume>, <fpage>1282</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr61-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Control of regulatory T cell development by the transcription factor FOXP3</article-title>. <source>Science</source> <volume>299</volume>, <fpage>1057</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr62-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>De Boer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>House</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>A short course of Mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of Interleukin-4 and alloantibody responses</article-title>. <source>Transplantation</source> <volume>76</volume>(<issue>8</issue>), <fpage>1159</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr63-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikehara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yasunami</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kodama</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>CD4<sup>+</sup> Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice</article-title>. <source>J Clin Invest</source> <volume>105</volume>, <fpage>1761</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr64-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jager</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kuchroo</surname>
<given-names>V. K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation</article-title>. <source>Scand J Immunol</source> <volume>72</volume>, <fpage>173</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr65-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Game</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Activated CD1d-restricted natural killer T cells secrete IL-2: Innate help for CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells?</article-title> <source>Eur J Immunol</source> <volume>35</volume>, <fpage>1193</fpage>–<lpage>200</lpage>.</citation>
</ref>
<ref id="bibr66-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Pernis</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Role of CD8<sup>+</sup> T cells in murine experimental allergic encephalomyelitis</article-title>. <source>Science</source> <volume>256</volume>, <fpage>1213</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr67-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joetham</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Naturally occurring lung CD4<sup>+</sup>CD25<sup>+</sup> T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β</article-title>. <source>J Immunol</source> <volume>178</volume>, <fpage>1433</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr68-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vahlenkamp</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>W. A. F.</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>M. B.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Preferential replication of FIV in activated CD4<sup>+</sup>CD25<sup>+</sup> T cells independent of cellular proliferation</article-title>. <source>Virol</source> <volume>321</volume>, <fpage>307</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr69-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapp</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Bucy</surname>
<given-names>R. P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>CD8<sup>+</sup> suppressor T cells resurrected</article-title>. <source>Human Immunol</source> <volume>69</volume>, <fpage>715</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr70-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapp</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Kapp</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>McKenna</surname>
<given-names>K. C</given-names>
</name>
</person-group>. (<year>2004</year> <article-title>). γδ T cells play an essential role in several forms of tolerance</article-title>. <source>Immunol Res</source> <volume>29</volume>(<issue>1</issue>), <fpage>93</fpage>–<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr71-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapp</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The role of γδ TCR-bearing T cells in oral tolerance</article-title>. In <source>Proceedings of the 72nd Forum in Immunology: Tolerance and Immunity in the Mucosal Immune System</source>, pp. <fpage>561</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr72-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kapp</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Oral antigen inhibits priming of CD8<sup>+</sup> CTL, CD4<sup>+</sup> T cells, and antibody responses while activating CD8<sup>+</sup> suppressor T cells</article-title>. <source>J Immunol</source> <volume>156</volume>, <fpage>916</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr73-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lake</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Kapp</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>γδ T lymphocytes regulate the induction and maintenance of oral tolerance</article-title>. <source>J Immunol</source> <volume>158</volume>, <fpage>3610</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr74-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Burt</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Ralph</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thistlethwaite</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Elkord</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Tremelimumab (anti-CTLA-4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells</article-title>. <source>Clinical Immunol</source> <volume>138</volume>, <fpage>85</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr75-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bettelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Awasthi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jager</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>IL-21 initiates an alternative pathway to induce proinflammatory T<sub>H</sub> 17 cells</article-title>. <source>Nature</source> <volume>448</volume>, <fpage>484</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr76-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bettelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Oukka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuchroo</surname>
<given-names>V. K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>IL-17 and T<sub>H</sub> 17 cells</article-title>. <source>Annu Rev Immunol</source> <volume>27</volume>, <fpage>485</fpage>–<lpage>517</lpage>.</citation>
</ref>
<ref id="bibr77-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krejsgaard</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gjerdrum</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Ralfkiaer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lauenborg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eriksen</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Mathiesen</surname>
<given-names>A.-M.</given-names>
</name>
<name>
<surname>Bovin</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Gniadecki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Geisler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ryder</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wasik</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Odum</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Woetmann</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Malignant T<sub>REG</sub> express low molecular splice forms of FOXP3 in Sézary syndrome</article-title>. <source>Leukemia</source> <volume>22</volume>, <fpage>2230</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr78-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kronenberg</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Antigens recognized by γδ T cells</article-title>. <source>Curr Opin Immunol</source> <volume>6</volume>, <fpage>64</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr79-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kullberg</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Jankovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gorelick</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Caspar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Letterio</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Cheever</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Sher</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Bacteria-triggered CD4<sup>+</sup> T regulatory cells suppress <italic>Helicobacter hepaticus</italic>-induced colitis</article-title>. <source>J Exp Med</source> <volume>196</volume>, <fpage>505</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr80-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuniyasu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Toda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Naturally anergic and suppressive CD25<sup>+</sup>CD4<sup>+</sup> T cells as a functionally and phenotypically distinct immunoregulatory T cell population</article-title>. <source>Int Immunol</source> <volume>12</volume>, <fpage>1145</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr81-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kursar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bonhagen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fensterle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kohler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hurwitz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kamradt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>S. H. E.</given-names>
</name>
<name>
<surname>Mittrucker</surname>
<given-names>H.-W.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Regulatory CD4<sup>+</sup>CD25<sup>+ </sup>T cells restrict memory CD8<sup>+</sup> T cell responses</article-title>. <source>J Exp Med</source> <volume>196</volume>, <fpage>1585</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr82-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larsen</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Elwood</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>D. Z.</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Hendrix</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tucker-Burden</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways</article-title>. <source>Nature</source> <volume>381</volume>(<issue>6581</issue>), <fpage>434</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr83-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le</surname>
<given-names>N. T.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Regulating regulatory T cells</article-title>. <source>Bone Marrow Transplant</source> <volume>39</volume>, <fpage>1</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr84-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehner</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation</article-title>. <source>Immunol</source> <volume>123</volume>, <fpage>40</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr85-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeMaoult</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krawice-Radanne</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dausset</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carosella</surname>
<given-names>E. D.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>HLA-GI-expressing antigen presenting cells induce immunosuppressive CD4<sup>+</sup> T cells</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>101</volume>, <fpage>7064</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr86-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenert</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brummel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Field</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Ashman</surname>
<given-names>R. F.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production</article-title>. <source>J Clin Immunol</source> <volume>25</volume>(<issue>1</issue>), <fpage>29</fpage>.</citation>
</ref>
<ref id="bibr87-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>M. I.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Special regulatory T cell review: FOXP3 biochemistry in regulatory T cells—how diverse signals regulate suppression</article-title>. <source>Immunol</source> <volume>123</volume>, <fpage>17</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr88-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Regulatory B cells in autoimmune diseases and mucosal immune homeostasis</article-title>. <source>Autoimmunity</source> <volume>44</volume>(<issue>1</issue>), <fpage>58</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr89-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Broxmeyer</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Regulation of trafficking receptor expression in human forkhead box P3<sup>+</sup> regulatory T cells</article-title>. <source>J Immunol</source> <volume>177</volume>, <fpage>840</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr90-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nutsch</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Farr</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Koni</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Rudensky</surname>
<given-names>A. Y.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Differentiation of regulatory FOXP3<sup>+</sup> T cells in the thymic cortex</article-title>. <source>Proc Nat Acad Sciences</source> <volume>105</volume>(<issue>33</issue>), <fpage>11903</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr91-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> regulatory T cell depletion may attenuate the development of silica-induced lung fibrosis in mice</article-title>. <source>PLoS ONE</source> <volume>5</volume>(<issue>11</issue>), <fpage>1</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr92-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lourenco</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>La Cava</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Natural regulatory T cells in autoimmunity</article-title>. <source>Autoimmunity</source> <volume>44</volume>(<issue>1</issue>), <fpage>33</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr93-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundgren</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suri-Payer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Enarsson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Svennerholm</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Lundin</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Helicobacter pylori-specific CD4<sup>+</sup>CD25 high regulatory cells suppress memory T-cell responses to <italic>H. pylori</italic> in infected individuals</article-title>. <source>Infect Immun</source> <volume>71</volume>, <fpage>1755</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr94-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>G. Y. J.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3</article-title>. <source>J Exp Med</source> <volume>205</volume>, <fpage>1551</fpage>.</citation>
</ref>
<ref id="bibr95-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maggi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cosmi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liotta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Romagnani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Romagnani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Annunziato</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Thymic regulatory T cells</article-title>. <source>Autoimmunity Rev</source> <volume>4</volume>, <fpage>579</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr96-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malek</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Matsutani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adeegbe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>IL-2 family of cytokines in T regulatory cell development and homeostasis</article-title>. <source>J Clin Immunol</source> <volume>28</volume>, <fpage>635</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr97-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangan</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Harrington</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>O’Quinn</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Helms</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Bullard</surname>
<given-names>D. C.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Transforming growth factor-β induces development of the T<sub>H</sub> 17 lineage</article-title>. <source>Nature</source> <volume>441</volume>, <fpage>231</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr98-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menetrier-Caux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gobert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Caux</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Differences in tumor regulatory T-cell localization and activation status impact patient outcome</article-title>. <source>Cancer Res</source> <volume>69</volume>, <fpage>7895</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr99-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>1968</year>). <article-title>Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes</article-title>. <source>J Exp Med</source> <volume>128</volume>, <fpage>821</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr100-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizoguchi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Preffer</surname>
<given-names>F. I.</given-names>
</name>
<name>
<surname>Bhan</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Regulatory role of mature B cells in a murine model of inflammatory bowel disease</article-title>. <source>Int Immunol</source> <volume>12</volume>(<issue>5</issue>), <fpage>597</fpage>–<lpage>605</lpage>.</citation>
</ref>
<ref id="bibr101-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montagnoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bacci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bozza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gaziano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mosci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sharpe</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Romani</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>B7/CD28-dependent CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cells are essential components of the memory-protective immunity to Candida albicans</article-title>. <source>J Immunol</source> <volume>169</volume>, <fpage>6298</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr102-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosier</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>1967</year>). <article-title>A requirement for two cell types for antibody formation <italic>in vitro</italic>
</article-title>. <source>Science</source> <volume>158</volume>, <fpage>1573</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr103-0192623311430693">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Mowat</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Oral tolerance and regulation of immunity to dietary antigens. In Handbook of Mucosal Immunology</article-title> (<person-group person-group-type="editor">
<name>
<surname>Ogra</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Mestecky</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lamm</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Strober</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>McGhee</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Bienenstock</surname>
<given-names>J.</given-names>
</name>
</person-group>, eds.), pp. <fpage>185</fpage>–<lpage>201</lpage>. <publisher-name>Academic Press</publisher-name>, <publisher-loc>San Diego, CA</publisher-loc>.</citation>
</ref>
<ref id="bibr104-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>Y. D.</given-names>
</name>
<name>
<surname>Golshayan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ehirchiou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wekerle</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seebach</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Buhler</surname>
<given-names>L. H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>T regulatory cells in xenotransplantation</article-title>. <source>Xenotransplantation</source> <volume>16</volume>, <fpage>121</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr105-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munk</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Schoel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Modrow</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karr</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>S. H. E.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-Kilodalton heat shock protein</article-title>. <source>J Immunol</source> <volume>143</volume>, <fpage>2844</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr106-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Faunce</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Gumperz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yamamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stein-Streilein</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>CD4<sup>+</sup> NKT cells, but not conventional CD4<sup>+</sup> T cells, are required to generate efferent CD8<sup>+</sup> T regulatory cells following antigen inoculation in an immune-privileged site</article-title>. <source>J Immunol</source> <volume>171</volume>, <fpage>1266</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr107-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nandakumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C. W. T.</given-names>
</name>
<name>
<surname>Kumarguru</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>T regulatory cells: An overview and intervention techniques to modulate allergy outcome</article-title>. <source>Clin Mol Allergy</source> <volume>7</volume>, <fpage>5</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr108-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasr</surname>
<given-names>I. W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Diggs</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Tellides</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lakkis</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells</article-title>. <source>J Immunol</source> <volume>174</volume>, <fpage>6161</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr109-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niederkorn</surname>
<given-names>J. Y.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Emerging concepts in CD8<sup>+</sup> T regulatory cells</article-title>. <source>Curr Opin Immunol</source> <volume>20</volume>, <fpage>327</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr110-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nistala</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wedderburn</surname>
<given-names>L. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>T<sub>H</sub> 17 and regulatory T cells: Rebalancing pro- and anti-inflammatory forces in autoimmune arthritis</article-title>. <source>Rheumatol</source> <volume>48</volume>, <fpage>602</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr111-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nizar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Galustian</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dalgleish</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>T regulatory cells, the evolution of targeted immunotherapy</article-title>. <source>Biochim Biophys Acta</source> <volume>1806</volume>, <fpage>7</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr112-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochs</surname>
<given-names>H. D.</given-names>
</name>
<name>
<surname>Khattri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Brunkow</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and the Scurfy mutant mouse</article-title>. <source>Immunol Allergy Clin of North America</source> <volume>22</volume>, <fpage>357</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr113-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Connor</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Anderton</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>FOXP3<sup>+</sup> regulatory T cells in the control of experimental CNS autoimmune disease</article-title>. <source>J Neuroimmunol</source> <volume>193</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr114-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohkura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hamaguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>FOXP3<sup>+</sup> regulatory T cells: Control of FOXP3 expression by pharmacological agents</article-title>. <source>Trends Pharmacol Sci</source> <volume>32</volume>(<issue>3</issue>), <fpage>158</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr115-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okumura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takemori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tokuhisa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tada</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1977</year>). <article-title>Specific enrichment of the suppressor T cell bearing I-J determinants: Parallel functional and serological characterizations</article-title>. <source>J Exp Med</source> <volume>146</volume>, <fpage>1234</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr116-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakae</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pawankar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Role of regulatory and proinflammatory T cell populations in allergic diseases</article-title>. <source>WAO J</source> <volume>1</volume>, <fpage>9</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr117-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oswald-Richter</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Grill</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Shariat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Leelawong</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sundrud</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Unutmaz</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells</article-title>. <source>PLOS Biology</source> <volume>2</volume>(<issue>7</issue>), <fpage>955</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr118-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozdemir</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Akdis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akdis</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>T regulatory cells and their counterparts: Masters of immune regulation</article-title>. <source>Clin Exp Allergy</source> <volume>39</volume>, <fpage>626</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr119-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandiyan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lenardo</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4<sup>+</sup> T cells</article-title>. <source>Nature Immunol</source> <volume>8</volume>, <fpage>1353</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr120-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>D. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Escape from tolerance in the human X-linked autoimmunity-allergic dysregulation syndrome and the <italic>Scurfy</italic> mouse</article-title>. <source>J Clin Invest</source> <volume>107</volume>(<issue>2</issue>), <fpage>155</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr121-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powrie</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Leach</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Mauze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Caddle</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Coffman</surname>
<given-names>R. L.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Inhibition of T<sub>H</sub>1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RB <sub>high</sub> CD4<sup>+</sup> T cells</article-title>. <source>Immunity</source> <volume>1</volume>(<issue>7</issue>), <fpage>553</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr122-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quezada</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Jarvinen</surname>
<given-names>L. Z.</given-names>
</name>
<name>
<surname>Lind</surname>
<given-names>E. F.</given-names>
</name>
<name>
<surname>Noelle</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>CD40/CD154 interactions at the interface of tolerance and immunity</article-title>. <source>Ann Rev Immunol</source> <volume>22</volume>(<issue>1</issue>), <fpage>307</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr123-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Read</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Malstrom</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Powrie</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Cytotoxic T lymphocyte-associated antigen-4 plays an essential role in the function of CD25<sup>+</sup>CD4<sup>+</sup> regulatory cells that control intestinal inflammation</article-title>. <source>J Exp Med</source> <volume>192</volume>, <fpage>295</fpage>–<lpage>302</lpage>.</citation>
</ref>
<ref id="bibr124-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reigert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bar-Or</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>B-cell-derived Interleukin-10 in autoimmune disease: Regulating the regulators</article-title>. <source>Nat Rev Immunol</source> <volume>8</volume>(<issue>6</issue>), <fpage>486</fpage>.</citation>
</ref>
<ref id="bibr125-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riley</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>June</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Blazar</surname>
<given-names>B. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Human T regulatory cell therapy: Take a billion or so and call me in the morning</article-title>. <source>Immunity</source> <volume>30</volume>, <fpage>656</fpage>–<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr126-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Guerin</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Bromfield</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Branson</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Ahistrom</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Care</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Seminal fluid drives expansion of the CD4<sup>+</sup>CD25<sup>+</sup> T regulatory cell pool and induces tolerance to paternal alloantigens in mice</article-title>. <source>Biol Reprod</source> <volume>80</volume>(<issue>5</issue>), <fpage>1036</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr127-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The role of semen in induction of maternal immune tolerance to pregnancy</article-title>. <source>Semin Immunol</source> <volume>13</volume>, <fpage>243</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr128-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romagnani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Liotta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cosmi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Annunziato</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Properties and origin of human T<sub>H</sub> 17 cells</article-title>. <source>Mol Immunol</source> <volume>47</volume>, <fpage>3</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr129-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roncador</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Maestre</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martinez-Torrecuadrada</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>K.-L</given-names>
</name>
<name>
<surname>Pratap</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Toms</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Cerundolo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Powrie</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Banham</surname>
<given-names>A. H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Analysis of FOXP3 protein expression in human CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells at the single-cell level</article-title>. <source>Eur J Immunol</source> <volume>35</volume>, <fpage>1681</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr130-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roncarolo</surname>
<given-names>M.-G.</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans</article-title>. <source>Nature Rev: Immunol</source> <volume>7</volume>, <fpage>585</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr131-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roncarolo</surname>
<given-names>M.-G.</given-names>
</name>
<name>
<surname>Gregori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bacchetta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fleischhauer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Levings</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Interleukin-10-secreting type 1 regulatory T cells in rodents and humans</article-title>. <source>Immunol Rev</source> <volume>212</volume>, <fpage>28</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr132-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Naturally arising FOXP3-expressing CD25<sup>+</sup>CD4<sup>+</sup> regulatory T cells in immunological tolerance to self and non-self</article-title>. <source>Nature Immunol</source> <volume>6</volume>(<issue>4</issue>), <fpage>345</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr133-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Toda</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Immunologic self-tolerance maintained by activated T cells expressing IL-2 recpetor alpha-chains (CD25)</article-title>. <article-title>Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases</article-title>. <source>J Immunol</source> <volume>155</volume>, <fpage>1151</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr134-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Regulatory T cells and immune tolerance</article-title>. <source>Cell</source> <volume>133</volume>, <fpage>775</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr135-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samy</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>K. S. K.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Continuous control of autoimmune disease by antigen-dependent polyclonal CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells in the regional lymph node</article-title>. <source>J Exp Med</source> <volume>202</volume>, <fpage>771</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr136-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarris</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>K. G.</given-names>
</name>
<name>
<surname>Randow</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mayr</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Betz</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition</article-title>. <source>Immunity</source> <volume>28</volume>, <fpage>402</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr137-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Higuma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shiozaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Decidual and peripheral blood CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells in early pregnancy subjects and spontaneous abortion cases</article-title>. <source>Mol Hum Reprod</source> <volume>10</volume>, <fpage>347</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr138-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholzen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Minigo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Plebanski</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Heroes or villains? T regulatory cells in malaria infection</article-title>. <source>Trends in Parasitol</source> <volume>26</volume> (<issue>1</issue>), <fpage>16</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr139-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>R. H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Natural regulatory T cells and self-tolerance</article-title>. <source>Nature Immunol</source> <volume>6</volume>(<issue>4</issue>), <fpage>327</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr140-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tokura</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Downregulation of innate and acquired antitumor immunity by bystander γδ and αβ T lymphocytes with T<sub>H</sub>2 or Tr1 cytokine profiles</article-title>. <source>J Interferon and Cytokine Res</source> <volume>19</volume>, <fpage>555</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr141-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tokura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takigawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Egawa</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Depletion of IL-10 and TGF-β producing regulatory γδ T cells by administering a Daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells</article-title>. <source>J Immunol</source> <volume>163</volume>, <fpage>242</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr142-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalev</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Foerster</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maknojia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The novel CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cell effector molecule fibrinogem-like protein-2 contributes to the outcome of murine fulminant viral hepatitis</article-title>. <source>Hepatology</source> <volume>49</volume>(<issue>2</issue>), <fpage>387</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr143-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Activation of CD8<sup>+</sup> regulatory T-cells by human placental trophoblasts</article-title>. <source>J Immunol</source> <volume>174</volume>, <fpage>7539</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr144-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shevach</surname>
<given-names>E. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mechanisms of FOXP3<sup>+</sup> T regulatory cell-mediated suppression</article-title>. <source>Immunity</source> <volume>30</volume>, <fpage>636</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr145-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Muniappan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Wain</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Houser</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Hoerbelt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Long-term acceptance of porcine pulmonary allografts without chronic rejection</article-title>. <source>Transplant Proc</source> <volume>37</volume>(<issue>1</issue>), <fpage>72</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr146-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegmund</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Feuerer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Siewert</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo</article-title>. <source>Blood</source> <volume>106</volume>, <fpage>3097</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr147-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Special regulatory T-cell review: Regulation of immune responses-examining the role of T cells</article-title>. <source>Immunol</source> <volume>123</volume>, <fpage>13</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr148-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sindram-Trujillo</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Scherjon</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>van Hulst-van Miert</surname>
<given-names>P. P.</given-names>
</name><name>
<surname>Kanhai</surname>
<given-names>H. H.</given-names>
</name><name>
<surname>Roelen</surname>
<given-names>D. L.</given-names>
</name><name>
<surname>Claas</surname>
<given-names>F. H.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Comparison of decidual leukocytes following spontaneous vaginal delivery and elective caesarean section in uncomplicated human term pregnancy</article-title>. <source>J Reprod Immunol</source> <volume>62</volume>, <fpage>125</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr149-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strober</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Double-negative (CD4<sup>−</sup>CD8<sup>−</sup> alpha beta<sup>+</sup>) T cells which promote tolerance induction and regulate autoimmunity</article-title>. <source>Immunol Rev</source> <volume>149</volume>, <fpage>217</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr150-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suvas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Azkur</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Kumaraguru</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Rouse</surname>
<given-names>B. T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells control the severity of viral immunoinflammatory lesions</article-title>. <source>J Immunol</source> <volume>172</volume>, <fpage>4123</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr151-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taglauer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trikhacheva</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Slusser</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Petroff</surname>
<given-names>M. G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Expression and function of PDCDI at the human maternal-fetal interface</article-title>. <source>Biol Reprod</source> <volume>79</volume>, <fpage>562</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr152-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takenoshita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kumamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iwadate</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The role of TGF-β in digestive organ disease</article-title>. <source>J Gastroenterol</source> <volume>37</volume>(<issue>12</issue>), <fpage>991</fpage>.</citation>
</ref>
<ref id="bibr153-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Krummel</surname>
<given-names>M. F.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Imaging the function of regulatory T-cells in vivo</article-title>. <source>Curr Opin Immunol</source> <volume>18</volume>, <fpage>496</fpage>–<lpage>502</lpage>.</citation>
</ref>
<ref id="bibr154-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>de Zoeten</surname>
<given-names>E. F.</given-names>
</name>
<name>
<surname>Ozkaynak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Hancock</surname>
<given-names>W. W.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Histone deacetylase inhibitors and transplantation</article-title>. <source>Curr Opin Immunol</source> <volume>19</volume>, <fpage>589</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr155-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Blazar</surname>
<given-names>B. R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The infusion of <italic>ex vivo</italic> activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality</article-title>. <source>Blood</source> <volume>99</volume>, <fpage>3493</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr156-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Te Velde</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Verstege</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Hommes</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Critical appraisal of the current practice in murine TNBS-induced colitis</article-title>. <source>Inflammatory Bowel Diseases</source> <volume>12</volume>(<issue>10</issue>), <fpage>995</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr157-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thorburn</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Hansbro</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Harnessing regulatory T cells to suppress asthma: From potential to therapy</article-title>. <source>Am J Respir Cell Mol Biol</source> <volume>43</volume>, <fpage>511</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr158-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thuere</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zenclussen</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Shumacher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Langwisch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schulte-Wrede</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Teles</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paeschke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Volk</surname>
<given-names>H. D.</given-names>
</name>
<name>
<surname>Zenclussen</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Kinetics of regulatory T cells during murine pregnancy</article-title>. <source>Am J Reprod Immunol</source> <volume>58</volume>, <fpage>514</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr159-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zekzer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hanssen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Olcott</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>D. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Lipopolysaccharide-activated B cells down-regulate T<sub>H</sub>1 immunity and prevent autoimmune diabetes in non-obese diabetic mice</article-title>. <source>J Immunol</source> <volume>167</volume>(<issue>2</issue>), <fpage>1081</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr160-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilburgs</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Roelen</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>van der Mast</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>de Groot-Swings</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Kleijburg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scherjon</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Claas</surname>
<given-names>F. H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Evidence for a selective migration of fetus-specific CD4<sup>+</sup>CD25 bright regulatory T cells from the peripheral blood to the decidua in human pregnancy</article-title>. <source>J Immunol</source> <volume>180</volume>, <fpage>5737</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr161-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trentham</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Townes</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>A. H.</given-names>
</name>
</person-group> (<year>1977</year>). <article-title>Autoimmunity to type II collagen in an experimental model of arthritis</article-title>. <source>J Exp Med</source> <volume>146</volume>(<issue>3</issue>), <fpage>857</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr162-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trowsdale</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Betz</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Mother’s little helpers: Mechanisms of maternal-fetal tolerance</article-title>. <source>Nat Immunol</source> <volume>7</volume>, <fpage>241</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr163-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trzonkowski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bieniaszewska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Juscinska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dobyszuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krzystyniak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marek</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mysliwska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hellmann</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>First-in-man clinical results of the treatment of patients with graft versus host disease with human <italic>ex vivo</italic> expanded CD4<sup>+</sup>CD25<sup>+</sup>CG127<sup>−</sup> T regulatory cells</article-title>. <source>Clinical Immunol</source> <volume>133</volume>, <fpage>22</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr164-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vadas</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>I. F</given-names>
</name>
<name>
<surname>Chism</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Boyse</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Gamble</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Whitelaw</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression</article-title>. <source>J Exp Med</source> <volume>144</volume>, <fpage>10</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr165-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vahlenkamp</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Tompkins</surname>
<given-names>W. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4<sup>+</sup>CD25<sup>+ </sup>T regulatory cells</article-title>. <source>I Immunol</source> <volume>172</volume>, <fpage>4752</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr166-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veldhoen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hocking</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Atkins</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Locksley</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Stockinger</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>TGF-β in the context of an inflammatory cytokine milieu supports <italic>de novo</italic> differentiation of IL-17-producing T cells</article-title>. <source>Immunity</source> <volume>24</volume>, <fpage>179</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr167-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Roglic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McKune</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Guerder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>MacKay</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dembic</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Qa-1 restricted recognition of foreign antigen by a γδ T cell hybridoma</article-title>. <source>Nature</source> <volume>340</volume>, <fpage>646</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr168-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vignali</surname>
<given-names>D. A. A.</given-names>
</name>
<name>
<surname>Collison</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Workman</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>How regulatory T cells work</article-title>. <source>Nature Rev Immunol</source> <volume>8</volume>, <fpage>523</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr169-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Von Boehmer</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Mechanisms of suppression by suppressor T cells</article-title>. <source>Nature Immunol</source> <volume>6</volume>(<issue>4</issue>), <fpage>338</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr170-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>“Yin-yang” functions of transforming growth factor-β and T regulatory cells in immune regulation</article-title>. <source>Immunol Rev</source> <volume>220</volume>, <fpage>199</fpage>–<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr171-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Harrington</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Mangan</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Gavriell</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>T<sub>H</sub> 17 an effector CD4 T cell lineage with regulatory T cell ties</article-title>. <source>Immunity</source> <volume>24</volume>, <fpage>677</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr172-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Ardito</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moise</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>De Groot</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>T cell epitope: Friend or foe? Immunogenicity of biologics in context</article-title>. <source>Adv Drug Delivery Rev</source> <volume>61</volume>, <fpage>965</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr173-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiner</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Oral tolerance: Immune mechanisms and treatment of autoimmune diseases</article-title>. <source>Immunology Today</source> <volume>18</volume>(<issue>7</issue>), <fpage>335</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr174-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiner</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>al-Sabbagh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens</article-title>. <source>Ann Rev Immunol</source> <volume>12</volume>, <fpage>809</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr175-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welters</surname>
<given-names>M. J. P.</given-names>
</name>
<name>
<surname>Piersma</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>van der Burg</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>T regulatory cells in tumour-specific vaccination strategies</article-title>. <source>Expert Opin Biol Ther</source> <volume>8</volume>(<issue>9</issue>), <fpage>1365</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr176-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wirnsberger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hinterberger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes</article-title>. <source>Immunol and Cell Biol</source> <volume>89</volume>, <fpage>45</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr177-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Dittel</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Hardardottir</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Janeway</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice</article-title>. <source>J Exp Med</source> <volume>184</volume>(<issue>6</issue>), <fpage>2271</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr178-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Workman</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Vignali</surname>
<given-names>D. A. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Negative regulation of T cell homeostasis by LAG-3 (CD223)</article-title>. <source>J Immunol</source> <volume>174</volume>, <fpage>688</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr179-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xhao</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Fetal alloantigen is responsible for the expansion of the CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cell pool during pregnancy</article-title>. <source>J Reprod Immunol</source> <volume>75</volume>, <fpage>71</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr180-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanaba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bouaziz</surname>
<given-names>J.-D.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Poe</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tedder</surname>
<given-names>T. F.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A regulatory B cell subset with a unique CD1d hi CD5<sup>+</sup> phenotype controls T cell-dependent inflammatory responses</article-title>. <source>Immunity</source> <volume>28</volume>(<issue>5</issue>), <fpage>639</fpage>.</citation>
</ref>
<ref id="bibr181-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Proportional change of CD4<sup>+</sup> CD25 + regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients</article-title>. <source>Fertil Steril</source> <volume>89</volume>, <fpage>656</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr182-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Generation of HSP60-specific regulatory T cells and effect on atherosclerosis</article-title>. <source>Cell Immunol</source> <volume>243</volume>, <fpage>90</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr183-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Role and mechanisms of CD4 + CD25 + regulatory T cells in the induction and maintenance of transplantation tolerance</article-title>. <source>Transplant Immunol</source> <volume>17</volume>, <fpage>120</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr184-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dejbakhsh-Jones</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Bone marrow NK1.1<sup>−</sup> and NK1.1<sup>+</sup> T cells reciprocally regulate acute graft versus host disease</article-title>. <source>J Exp Med</source> <volume>189</volume>, <fpage>1073</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr185-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>G. Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>S. I.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>FOXP3 as a marker of tolerance induction versus rejection</article-title>. <source>Curr Opin Organ Transplant</source> <volume>14</volume>, <fpage>40</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr186-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z. X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway</article-title>. <source>J Immunol</source> <volume>177</volume>, <fpage>6920</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr187-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Fetal alloantigen is responsible for the expansion of the CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cell pool during pregnancy</article-title>. <source>J Reprod Immunol</source> <volume>75</volume>, <fpage>71</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr188-0192623311430693">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>I. I.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>TGF-β-induced FOXP3 inhibits T<sub>H</sub> 17 cell differentiation by antagonizing RORγt function</article-title>. <source>Nature</source> <volume>453</volume>, <fpage>236</fpage>–<lpage>40</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>